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ABSTRACT OF THE DISSERTATION 
Molecular and Epigenetic Regulation of Stem Cell Radiosensitivity 
by 
Keith Michael Jacobs 
Doctor of Philosophy in Biology and Biomedical Sciences 
Molecular Cell Biology 
Washington University in St. Louis, 2015 
Professor Dennis Hallahan, Chair 
 
Normal tissue injury resulting from ionizing radiation (IR) during cancer radiotherapy has been attributed 
to reduced regenerative capacity of stem cell compartments. Utilizing multiple in vivo tissue niches and 
primary culture models, we demonstrate that normal stem cells are highly radiosensitive while their 
isogenic, directly differentiated progeny are radioresistant. Stem cell dropout is therefore likely 
responsible for the resulting radiation injury in these niches. This differential radiosensitivity is 
independent of proliferation status, and increased IR-induced apoptosis in stem cells is more broadly 
distributed across the cell cycle. 
We elucidate that stem cells exhibit an attenuated DDR resulting in aberrant cell cycle checkpoint 
activation and severely diminished DNA repair capacity despite normal sensing of DNA double strand 
breaks. Interestingly, while these stem cells are unable to induce γH2AX foci, apoptosis induces pan-
nuclear H2AX S139 phosphorylation together with activation of MST1 and JNK. This apoptotic signaling 
corresponds to a unique inability of stem cells to dephosphorylate H2AX-Y142 around break sites, which 
promotes apoptosis through JNK while inhibiting DDR signaling. By investigating these molecular 
responses for the first time in stem cells, we provide potential mechanisms for IR-induced apoptosis 
independent of DDR signaling. The abrogated DDR in stem cells is also associated with constitutively 
elevated histone-3 lysine-56 acetylation, which contributes to IR-induced apoptosis through restriction of 
the DDR and can be modulated to impart radioprotection on stem cells. 
 xi 
 
This data establishes that unique epigenetic landscapes among differing cell types can impart 
heterogeneity in the DDR, resulting in varying radiosensitivities and challenging prior assumptions about 
the ubiquitous nature of canonical DDR signaling. We thus identify pluralistic molecular and epigenetic 
mechanisms that collectively contribute to IR hypersensitivity in stem cells, promoting development of 
future therapeutic strategies for minimizing deleterious sequelae from radiotherapy.  
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CHAPTER 1 
Introduction 
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1.1  RADIATION THERAPY 
Radiation therapy is commonly used to destroy localized tumors in cancer patients.  Radiation therapy 
utilizes ionizing radiation (IR) to kill cancer cells through the induction of damaging DNA double-strand 
breaks (DSBs).  DSBs are more detrimental than single strand breaks because DSBs do not have an 
undamaged strand available to use as a repair template.  DSBs may ultimately lead to chromosomal 
aberrations which severely impinge on genomic integrity1.  Unfortunately, tumors often evolve resistance 
to DNA damage-induced cell death through inactivation of apoptosis pathways2,3. Additionally, cancer 
stem cells within many tumors are believed to be especially radioresistant4,5 and can inhibit complete 
eradication of the tumor6.  The relative radioresistance of cancer cells requires the use of increased and 
repeated IR doses, which often result in injury to normal tissue8.   
 
1.1.1 Physics of Ionizing Radiation 
Ionizing radiation is defined as radiation that imparts enough energy to cause ejection of one or 
more electrons from its target atoms, resulting in the localized release of energy8.  The energy 
released per displaced electron is approximately 33eV, which is enough energy to break chemical 
bonds of nearby molecules.  Ionizing radiation can be classified as either electromagnetic or 
particulate. IR induces DSBs both directly through the energy imparted from the radiation as well 
as indirectly by the creation of highly reactive hydroxyl radicals (reactive oxygen species or ROS) 
from nearby water or other molecules8,9. Only particulate radiation typically imparts enough energy 
to directly induce DNA breaks, while all forms of radiation can induce indirect ionization. X-rays 
and γ-rays are electromagnetic radiation, while atomic particles and heavy ions represent 
particulate radiation. X-rays are created by focusing the kinetic energy produced from accelerated 
electrons, while gamma rays emanate through natural decay of radioactive isotopes. Atomic 
particle radiation includes electrons, protons, alpha particles and neutrons, all of which can be 
used for radiation therapy.  Heavy ions include the nuclei of carbon, neon, argon, or iron that have 
had electrons removed to create a positive charge and can be used for radiation therapy with 
specialized accelerators.  Heavy ions are also present in outer space and are a major potential 
danger for astronauts during long space voyages8. Ionizing radiation is typically measured as 
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absorbed dose in the unit of grays (Gy), which equals 100 rad or 1 Joule of deposited energy per 
kilogram of tissue10. There are also measures of effective dose, to account for differing biological 
effects of various forms of radiation relative to their respective linear energy transfer (LET), or the 
average amount of energy deposited per linear unit of length.  X-rays, electrons, gamma rays and 
protons exhibit a significantly lower LET than neutrons, alpha particles and heavy ions and 
therefore have a less efficient biological effect per dose 8. The sievert (Sv), which equals 100 rem, 
is the international unit for effective dose, and a Gray is similar to a Sievert for low LET radiation11. 
 
1.1.2 Cancer Radioresistance 
While radiation therapy is an often effective treatment for destroying cancer, inactivation of the 
apoptotic factor p53 and other evolutionary mutations impart radioresistance upon cancer cells2,3. 
Inactivation of DNA repair factors and the DNA Damage Response (discussed below) is often an 
important step in cellular transformation by promoting genomic instability and preventing the 
induction of programmed cell death12. While mutation of repair factors can indeed sensitize cancer 
cells, associated inhibition of apoptosis can promote resistance and further mutational evolution. 
Because of the common loss-of-function of apoptosis in cancer cells, cell death often involves 
other mechanisms. Cancer cells often die through mitotic catastrophe, whereby residual 
unrepaired DNA damage results in severe chromosomal defects following mis-segregation during 
mitosis, leading to delayed p53-independent apoptosis.  Additionally, DNA damage may induce 
senescence in cancer, which does not destroy cells but stops their division and therefore can halt 
the proliferation of a tumor3,13. 
 
While their existence is still debated, cancer stem cells are believed to be extremely radioresistant, 
thereby contributing to the overall radioresistance of tumors and promoting cancer recurrence 6,14. 
Cancer stem cells exhibit resistance in part through elevated DNA Damage Response signaling, 
increased aldehyde dehydrogenase and ABC transporter activity (which are less important for 
radiation but can  inactivate or remove chemotherapeutic drugs), a hypoxic microenvironment,  
increased free-radical scavengers, activation of self-renewal pathways and even potentially 
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reduced proliferation4–6,14–16.  Unique strategies to target these mechanisms may be required in 
conjunction with radiation treatment in order to sufficiently destroy cancer stem cells. 
 
1.1.3 Whole Body Irradiation Dosage and Mortality 
In addition to the relative radioresistance of tumors, the effectiveness of radiation therapy is also 
limited by clinical side effects on normal tissue. Acute clinical consequences of accidental whole-
body radiation exposure such as from nuclear disasters are dosage-dependent.  Doses below 2Gy 
are considered subclinical and may only result in a temporary drop in blood cell counts along with 
some mild nausea or headache. Hematopoietic injury and white blood cell loss occurs at doses of 
2Gy and above, which can lead to death within 30 days from bone marrow depletion due to 
infection or hemorrhaging10. During this hematopoietic syndrome, rapid depletion of lymphocytes 
is followed by gradual reduction in granulocytes, platelets and red blood cells, leading to impaired 
immunity, poor wound healing and excessive bleeding. Exposure to single doses of 10Gy and 
above produce gastrointestinal damage and potential death within 2-3 weeks from organ failure, 
sepsis and internal bleeding, with symptoms including loss of nutrient absorption, severe nausea 
and vomiting, diarrhea, anorexia and abdominal pain. More global effects can be observed above 
10Gy, with patients experiencing “fatigue syndrome” consisting of central nervous system 
manifestations such as fever, headache, disorientation, reduced reflexes, diminished coordination 
and even occasional loss of consciousness.  Exposure to more than 30Gy induces cardiovascular 
and central nervous system failure resulting in death within a few days due to loss of blood vessel 
integrity and brain swelling/inflammation. All of these doses also induce nausea and vomiting 
within the first 12 hours following exposure11.   
 
1.1.3.1 Linear No-Threshold Hypothesis 
Exposure to doses below 1Gy does not result in any significant risk of tissue injury, 
although continued exposure does increase cancer risk in a dose-dependent 
manner11,17,18. The linear no-threshold (LNT) hypothesis proposes that any and all doses 
of radiation pose some cancer risk, and therefore no “safe” levels of radiation exist 17,18. 
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This hypothesis is faulty however, and acute doses below 100mSv or continued exposure 
below 500mSv fails to promote any increased cancer risk.  In contrast, strong evidence 
exists for beneficial effects of exposure to very low levels of radiation, known as hormesis. 
Radiation hormesis develops within hours of exposure and its effects can last up to 
months, including reduction of reactive oxygen species, death of previously damaged 
cells, immune stimulation, and modification of cell cycle parameters including senescence. 
These adaptive mechanisms all combine to protect long term genomic integrity and 
reduce the risk of future carcinogenesis17,19. 
 
1.1.4 Chronic and late effects of radiation injury 
Consequences of localized normal tissue injury include both acute and chronic sequelae such as 
hematopoietic dysfunction20, cognitive impairment21,22, infertility23, intestinal epithelial erosion24,25 
and hair loss26. These pathologies result from deficient tissue regeneration following normal cell 
turnover and thus have been attributed to the depletion of regenerative stem cell 
compartments7,27,28. The timing of the clinical onset of these symptoms is therefore dictated by the 
turnover rate of the affected tissue, with early consequences presenting only days or weeks 
following irradiation in rapidly dividing tissues and late-onset effects in slow-dividing tissues7. 
 
Many chronic symptoms only present months to years following radiation damage and are not 
related to stem cell loss or tissue proliferation rate. The processes involved in this type of injury 
include fibrosis, necrosis, inflammation, atrophy, and vascular damage7,29.  These mechanisms all 
interact in creating long-term damage. Fibrosis is excessive scarring due to overactive wound 
healing and is probably the most common type of injury following radiation damage30, appearing 
often among stromal cells of many tissues. Tissue necrosis and atrophy result in degeneration of 
the affected tissue. Necrosis is most damaging to the cerebral white matter of the brain while 
atrophy is characterized by sequential destruction of epithelial tissue. Endothelial cell damage and 
immunological inflammation lead to reduced vascular integrity, causing further broad tissue 
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damage through ischemia. Inflammatory responses can promote many of the above mechanisms 
as well as tissue-specific forms of radiation injury such as pneumonitis in lung7,31,32.  
 
1.1.4.1 Radiation Dose Fractionation 
The requirement to balance tumor elimination while minimizing side effects limits the 
overall effectiveness of radiation therapy, so identifying methods for improved 
radioprotection of normal tissue is indispensible for improving the efficacy of cancer 
treatment7.  One treatment method that has been developed to maximize efficiency of cell 
killing on cancer cells while sparing normal tissue is dose fractionation. Dose fractionation 
attempts to take advantage of the differences in cell cycle kinetics and tissue 
microenvironment between tumor and normal tissue in order to bias cell killing toward 
cancer cells while sparing normal tissue. The effect of fractionation is based on the four 
“R” factors of radiobiology: repair of sublethal damage, cell cycle reassortment, 
reoxygenation, and repopulation.  Fractionation increases the effectiveness of radiation on 
destroying tumors because it allows reoxygenation of previously hypoxic cancer cells and 
promotes reassortment of cycling cells into more radiosensitive phases of the cell cycle.  
Hypoxic cells are resistant to ROS-mediated DNA damage, so repeated irradiation of 
tumors sensitizes previously hypoxic cancer cells once the aerated surrounding cells have 
died33. At the same time, fractionation spares normal tissue by allowing time for DNA 
repair and progenitor repopulation of damaged regions.  The dose, number and time delay 
of fractions must be calculated to maximize these benefits for each tissue type based on 
relative proliferation rate.  These factors must all be carefully determined when attempting 
to balance the sparing of fast-dividing normal tissues with effective killing of an entire 
tumor cell population34. 
 
1.1.5 Radiosensitivity and Proliferation 
Radiosensitivity differs greatly among tissues and cell types, and the cellular variables underlying 
differences in radiosensitivity have been studied for over a century. Two major determinants of 
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radiosensitivity include proliferation rate and cell cycle status. Bergonié and Tribondeau in 1906 
compared the radiosensitivity of various tissues and concluded that there was a direct correlation 
between proliferation rate and radiosensitivity for both normal and cancerous tissue35. This has 
since become a central tenet of radiobiology and continues to influence the interpretation of 
clinical outcomes from radiotherapy.  As might be expected however, the “Law of Bergonié and 
Tribondeau” is an oversimplification that has numerous counterexamples36.  Most notably, this 
tenet predicts that cancer cells should be inherently more radiosensitive than normal tissue due to 
their enhanced proliferation rate, however cancer is often relatively radioresistant 2,3. More 
accurately, highly proliferative cells appear to exhibit merely a faster response to radiation36,37, 
meaning that cell death will be observed earlier than in slower-dividing cells although not 
necessarily more extensively. 
 
1.1.6 Radiosensitivity and Cell Cycle Kinetics 
Radiosensitivity also varies across the cell cycle.  While there is certainly variability among cell 
types37, cells are typically most radiosensitive during G2/M phase, and especially during mitosis38–
40. Radiosensitivity is decreased during G1 phase and is minimal during the end of S phase.  
Differential radiosensitivity throughout the cell cycle has historically been performed by irradiating 
cells following synchronization by various cell cycle inhibitors, and some variability is also inherent 
based on the particular method used to achieve synchronization.  Live-sorting cells by flow 
cytometry to avoid the use of inhibitors has also demonstrated similar hypersensitivity of G2/M 
cells to low-dose IR41.  
 
1.2  MECHANISMS OF CELL DEATH 
There are many forms of cell death, each activated in response to particular conditions and stimuli within 
either the internal or external cellular environment.  Major mechanisms of cell death likely to result from 
radiation exposure are apoptosis, necrosis, mitotic catastrophe and autophagy.  There are also additional 
specialized forms of cell death unrelated to radiation damage such as anoikis (due to the loss of adhesive 
interactions with the extracellular matrix), entosis (non-phagocytic engulfment of one cell by another) and 
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cornification (formation of the outer epidermal layer of dead keratinocytes as part of normal skin 
development)42.  In addition to cell death, DNA damage and other stressors can also lead to replicative 
arrest or senescence43. 
  
 1.2.1 Necrosis 
Necrosis has historically been believed to be a passive cell death mechanism in response to 
tremendous external stress, resulting from conditions such as microbial toxins, immune 
activation, certain types of DNA damage, inadequate signaling ligand availability and insufficient 
nutrient access.  However, more recently it has been established that necrosis can also be a form 
of programmed cell death that is molecularly regulated as part of development and other normal 
physiological processes, often sharing signaling pathways with apoptosis. Unlike apoptosis 
however, the completion of necrosis results in cellular lysis, releasing cellular contents.  If 
necrosis occurs in response to infection, necrosis can thereby amplify infection by releasing 
microbes and toxins into the environment.  The release of cellular contents also induces an 
immune response which can potentially accentuate tissue damage42,44.   
 
1.2.2 Autophagy 
Autophagy is a cytoprotective response whereby stressed or dying cells isolate and degrade 
internal organelles in an attempt to preserve and recycle limited remaining resources.  Inducers of 
autophagy include starvation, absence of necessary growth factors and toxic agents.  While 
autophagy is considered a mechanism of cell death, except in the case of recycling cellular 
resources or stimulating immune activation in dying cells, it is typically an emergency protective 
mechanism. Autophagy attempts to maintain cellular homeostasis and energy reserves in order 
to prevent cell death. Autophagy therefore primarily accompanies cell death as opposed to 
regulating it, and inhibition of autophagy is often ineffective at preventing cell death induction42,45.   
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1.2.3 Mitotic Catastrophe 
Mitotic catastrophe is cell death stimulated by major errors during mitosis, inducing destruction of 
the cell either during mitosis or the subsequent G1 phase in order to prevent the propagation of 
damaging chromosomal aberrations to future generations.  Mitotic catastrophe can be identified 
by the presence of small micronuclei or multiple nuclei.  Mitotic catastrophe activates mitotic cell 
cycle arrest through the DNA Damage Response and results in either cell death through 
apoptosis/ necrosis or cell cycle exit as senescence.  Mitotic catastrophe is not a true 
independent mechanism of cell death but instead merely a checkpoint response that leads to cell 
death through one of the previously described mechanisms42. 
 
1.2.4 Senescence 
Senescence is sometimes considered to be a form of cell death, however despite not being able 
to further proliferate, senescent cells are otherwise functional and metabolically active. 
Senescence is most commonly enacted as “replicative senescence” due to the repeated 
shrinking of telomeres below a certain threshold over several generations of cell division.  
Shortening of telomeres activates the DNA Damage Response along with the cell cycle inhibitor 
tumor suppressors p53, retinoblastoma protein (Rb) and p16, leading to permanent inactivation of 
replicative capacity.  Senescence can also be prematurely induced by multiple kinds of stress, 
including exogenous DNA damage. It is considered to be a mechanism of tumor suppression 
because in addition to maintaining genomic integrity in future generations, senescence is actually 
induced in primary cells by the activation of oncogenes43.  Due to the inactivation of apoptosis in 
many cancers3,13, senescence is often the dominant mechanism for tumor suppression by DNA 
damaging agents. Senescent cells can be easily identified by their large, flat multinucleated 
morphology along with expression of senescence-associated β-galactosidase43. 
 
1.2.5 Apoptosis 
Apoptosis describes programmed cell death or “cellular suicide” through defined molecular 
signaling pathways.  Apoptosis can be enacted through either extrinsic or intrinsic mechanisms. 
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Extrinsic apoptosis induced programmed cell death through TNF family receptor-mediated 
signaling based on either the presence of toxic ligands or reduced concentration of necessary 
ligands.  Signal transduction leads to activation of the initiator caspases 8,9, or 10, which then 
activate the “executioner” caspases 3, 6 and 7.  Extrinsic apoptosis is caspase-dependent but 
does not always require mitochondrial permeabolization, which is an essential feature of the 
intrinsic pathway. Multiple internal cellular stresses are capable of activating the intrinsic pathway, 
including oxidative stress, DNA damage, accumulation of unfolded proteins, absence of growth 
factors, and others. The intrinsic apoptosis pathway is regulated by a homeostatic balance of pro 
and anti-apoptotic proteins. The Bcl-2 family of proteins include anti-apoptotic proteins such as 
Bcl-2, Bcl-x and Bcl-xL, along with pro-apoptotic proteins such as Bax, Bad, Bid and Bim.  
Apoptotic stimuli upregulate the relative amount of pro-apoptotic Bcl-2 family proteins, 
overcoming their inhibition by anti-apoptotic family members and leading to mitochrondrial 
permeabolization. Cytochrome c release from the permeabolized mitochondria induces formation 
of the apoptosome complex, activating caspase-9 which subsequently activates caspases 3, 6 
and 7.  Caspase-3 is the primary executioner caspase and activates several downstream 
substrates through cleavage, including caspase-activated DNase (CAD), which degrades nuclear 
DNA and promotes chromosomal condensation.  Caspase-3 also induces cytoskeletal changes 
and disintegration of the cell as a whole.  Caspase-independent apoptosis also occurs through 
proteins such as apoptosis inducing factor (AIF)46, which can directly induce DNA fragmentation 
and chromatin condensation42,47. Unlike necrosis, degraded cellular contents remain packaged 
within membranes during apoptosis, avoiding widespread immune activation and allowing 
phagocytic disposal of dead cells by macrophages44,47. 
 
1.2.5.1 p53 in Apoptosis 
p53 is the major transcriptional regulator of apoptosis, upregulating the expression of pro-
apoptotic Bcl-2 family members leading to mitochondrial permeabolization. p53 also 
transcriptionally activates several other genes that promote apoptosis, including 
phosphatase and tensin homolog (PTEN), an inhibitor of the pro-survival PI3 kinase 
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signaling pathway48. The action of p53 is controlled by numerous DNA damage-induced 
post-translational modifications which regulate its interaction with various substrates. p53 
protein is maintained at low levels under basal conditions due to constitutive ubiquination 
by Mouse double minute 2 homolog (MDM2).  The DNA Damage Response factors 
Ataxia telangiectasia mutated (ATM) and checkpoint kinase (Chk)1/2 phosphorylate p53 
on serine 15 and 20, stabilizing the protein by blocking MDM2-mediated ubiquination.  
Serine 46 is also phosphorylated, leading to induction of specific apoptotic genes, 
although the responsible kinase is not known.  p53 acetylation at multiple residues also 
promotes DNA binding and subsequent transcriptional activation of apoptotic genes49. 
 
1.2.5.2 MST1-JNK-H2AX Pathway 
Several overlapping pathways are involved in DNA fragmentation and chromatin 
condensation at the end stages of apoptosis downstream of caspase-3 activation.  One 
important downstream target of caspase-3 is mammalian Ste20-like kinase (MST1), an 
important kinase within the Hippo signaling pathway that controls organ size by 
promoting apoptosis during development50. Caspase-3 cleaves MST1, causing its 
translocation into the nucleus51.  DNA damage also induces autophosphorylation of 
MST1 on threonine 183, which combines with caspase cleavage to fully activate 
MST152,53. Upon activation and nuclear translocation, MST1 phosphorylates histone 
H2AX on serine 139 (S139). Phosphorylation of H2AX on S139 is required for DNA 
fragmentation and degradation at the end of apoptosis, as it appears to be responsible 
for recruiting caspase-activated DNase (CAD) to DNA51,54.  Histone H2B is also 
phosphorylated by MST1 in parallel with H2AX S139 phosphorylation and is responsible 
for apoptotic chromatin condensation55,56.  MST1 can additionally phosphorylate c-Jun N-
terminal kinase (JNK)57,58, which can in turn also pan-phosphorylate H2AX-S13954 to 
induce DNA fragmentation and chromatin condensation. 
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1.3  DNA DAMAGE RESPONSE 
DNA DSBs activate an intricate network of molecular signaling cascades known as the DNA damage 
response (DDR) (Fig. 1.1), which is an intricate network of molecular signaling that enables proper 
damage sensing, recruitment of repair factors  and DNA repair22–24. In mammals, the Mre11–Rad50–
Nbs1 (MRN) complex is involved in the initial sensing of DNA breaks25,26. The MRN complex binds broken 
DNA ends, holding them together and initiating the prerequisite end processing necessary for repair. 
Activation of ATM involves recruitment by MRN to DSBs25,27,28 together with autophosphorylation at serine 
1981 and subsequent cleavage of the ATM dimer26,28,29.  While the absolute requirements and specific 
order of ATM activation steps are unclear due to varying results across different cell types and assay 
conditions, the presence of broken DNA ends, the end resection activity of MRN, ATM 
autophosphorylation, and ATM monomerization all contribute to the maximal activation of ATM kinase 
following DNA damage62,66. Activated ATM then phosphorylates histone H2AX on serine 139 to create 
γH2AX67,68, which serves as a docking site for downstream repair factors69.  ATM is one member of the 
phosphatidylinositol 3-kinase-related kinases (PIKKs) along with ATM and Rad3-related (ATR) and DNA-
dependent protein kinase catalytic subunit (DNA-PKcs). All three PIKKs can compensate for loss of the 
others in γH2AX phosphorylation, however ATM is the primary PIKK for DSBs, while ATR is 
predominantly involved in signaling and repair of single-strand replication errors70 and DNA-PKcs 
primarily acts through non-homologous end joining DNA repair71,72. γH2AX has various important roles in 
the DDR, including recruitment of DDR factors, maintaining close proximity of broken DNA ends, signal 
amplification of the overall DDR response, and directly promoting DNA repair73. Mediator of DNA damage 
checkpoint protein 1 (MDC1) directly binds γH2AX, recruiting additional MRN and ATM which induces a 
positive feedback loop that promotes expansion of γH2AX for megabases around the DNA break and 
amplifies the DDR signal73–75. Additional DDR factors are also recruited, including several ubiquitin 
ligases and p53 binding protein 1 (53BP1) among others60, leading to activation of biological pathways 
such as cell cycle checkpoints and DNA repair.  If DNA damage cannot be sufficiently repaired, the DDR 
can also induce apoptosis by the activation of p53 through PIKKs and checkpoint proteins12,76.  Following 
completion of DNA repair, various phosphatases act to reverse DDR activation and return the chromatin 
to a baseline state77–83. 
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1.3.1 Cell Cycle Checkpoints 
In addition to phosphorylating H2AX, ATM phosphorylates Chk2 kinase and p53 among other 
proteins.  Activated Chk2 and ATM stabilize p53 in response to DSBs, leading to transcriptional 
activation of the protein p21.  p21 blocks cell cycle progression at the G1/S transition by inhibiting 
the action of cyclin/cdk complexes, while S-phase entry is further blocked through the 
degradation of cell division cycle 25A (Cdc25A) and other cyclins by ATM/Chk2. Chk1 is activated 
by ATR, which is most active during S phase, and both Chk1 and Chk2 can phosphorylate Wee1 
to block further cell cycle progression during S phase. Wee1 is also involved in G2 arrest, 
together with ATR and Chk1. G1 checkpoint arrest factors also play a role in initiating G2 arrest, 
but ATR and Chk1 are responsible for its maintenance84,85, while Cdc25A inhibition is also 
Figure 1.1. An overview of the DNA Damage Response. This diagram 
focuses on some of the important early molecular signaling and downstream 
biological outcomes investigated in this project. 
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involved.  Multiple cell cycle and other factors combine to mute the DDR response during 
mitosis38,86. In general cell cycle checkpoint proteins have primary roles during particular cell 
cycle phases, however they function together to promote arrest throughout the cell cycle.  
  
 1.3.2 DSB Repair 
DNA DSBs are typically repaired through one of two pathways, non-homologous end joining 
(NHEJ) or homologous recombination (HR).  NHEJ is a rapid process occurring primarily during 
G1 phase of the cell cycle. NHEJ is typically completed within 30min of DSB induction, however it 
is error-prone and can lead to mutations. HR in contrast is error free due to its utilization of a 
template DNA strand, however it can therefore only occur efficiently during S/G2 when sister DNA 
strands are available and usually requires several hours to complete1,87.  NHEJ begins with the 
Ku70/80 heterodimer binding the broken DNA ends and subsequently recruiting DNA-PKcs. The 
MRN complex aids with recruiting repair factors and processing broken DNA ends together with 
the protein Artemis88,89 , while a complex of proteins involving DNA ligase IV and X-ray repair 
cross-complementing protein 4 (XRCC4) ligates the broken DNA ends together1,59. HR is a 
relatively more complex process, beginning with the processing of DNA to create single-stranded 
overhangs by MRN and various nucleases59.  This single-stranded DNA is bound by replication 
protein A (RPA) and Rad51 as strand invasion occurs through the homologous template aided by 
other proteins such as breast cancer (BRCA)1/2 and Rad54, followed by DNA synthesis and 
resolution of the DNA junctions1,59. 
 
1.4  STEM CELLS 
Stem cells are non-specialized cell types that have the capacity to undergo asymmetric cell division, 
producing both a differentiated daughter cell and an identical daughter stem cell.  Daughter cells are 
capable of differentiating into any cell type within their defined lineage and tissue type90. Pluripotent stem 
cells such as embryonic stem (ES) cells are theoretically capable of producing progeny that differentiate 
into any cell type91, while tissue-specific or adult stem cells are multipotent and are restricted to 
differentiate only into cell types of that tissue.  Tissue-specific stem cells exist within well-defined niches, 
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a microenvironment consisting of surrounding support cells and differentiated progenitors. Stem cell 
function and regulation is controlled by signals from the surrounding niche as well as its internal signaling. 
These niches also regulate the proliferation of stem cells90,92.  
 
 1.4.1 Stem Cell Epigenetics 
 Stem cell pluripotency and overall gene expression is dictated by their epigenetic profile. Stem   
cells exhibit unique epigenetic regulation, including DNA hypomethylation, large areas of 
euchromatin and enhanced levels of specific histone modifications. DNA is wrapped and 
compacted around proteins known as histones within the nucleus to create a DNA-protein 
complex known as chromatin.  There are four core histones: H2A, H2B, H3, and H4, in addition to 
several histone variants.  Post-translational modifications on these histones can regulate gene 
transcription, and stem cells exhibit distinctive modulation of histone modifications that can 
control their pluripotency.  Pluripotency is associated with enrichment of both the activating mark 
histone 3 lysine 4 methylation as well as the repressive mark histone 3 lysine 27 methylation. 
This dual signature known as the “bivalent” chromatin structure maintains ES cells in a poised 
state for rapid transcription upon differentiation stimuli. Histone 3 lysine 4 methylation in particular 
gene regions is associated with reduced DNA methylation, which is repressive for transcription, 
further demonstrating the bivalent regulation of gene expression in stem cells.  Histone 3 lysine 
56 acetylation is also greatly elevated in embryonic stem cells and promotes expression of 
pluripotency genes93,94. 
 
 1.4.2 Proliferation and Cell Cycle in Stem Cells 
Many stem cell compartments contain both non-dividing quiescent stem cell populations as well 
as an additional pool of actively dividing stem cells.  These populations may be differentially 
involved in tissue regeneration following injury versus normal tissue turnover and homeostasis92.  
Embryonic stem cells are rapidly proliferating, and this rapid proliferation appears to be an 
important characteristic of pluripotency. Additionally, embryonic stem cells exhibit a shortened G1 
cell cycle phase that may also be involved in maintaining their undifferentiated state95–97. 
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Following DNA damage, both embryonic and neural stem cells both uniquely fail to activate G1 
checkpoint arrest95,96,98–101. The lack of G1 arrest in ES cells is associated with cytoplasmic 
sequestration of p53 102 and Chk2 99.  p21 protein is also absent in ES and neural stem cells, 
despite the expression of p21 mRNA96,98,100,103. 
  
 1.4.3 Maintaining Genomic Stability in Stem Cells 
Since stem cells are responsible for regenerating all of the differentiated cell types of a tissue, 
maintaining their genomic integrity is imperative.  Stem cells therefore exhibit multiple 
mechanisms for promoting genomic stability.  One method for preventing genomic instability in 
stem cells is elevated antioxidant defenses.  ES cells are resistant to high levels of damaging 
reactive oxygen species (ROS) due to higher expression of ROS-inactivating enzymes and 
maintain lower endogenous ROS levels than differentiated cells104,105.  They also show high 
expression of transporter and efflux pumps that can remove potentially damaging chemicals from 
the cell104. ES cells additionally express higher levels of heat shock proteins, which protect 
against the misfolding of proteins following cellular stress.  As another mechanism of genome 
protection, ES cells exhibit a low mutation rate, with baseline mutation frequencies up to 1000 
fold less than murine embryonic fibroblasts, at least at certain loci105,106. 
 
  1.4.3.1 DNA Damage Sensitivity 
While embryonic stem cells demonstrate robust mechanisms for maintaining genomic 
stability under baseline conditions, ES and neural stem cells in culture are extremely 
sensitive to elevated levels of DNA damage and readily undergo DNA damage-induced 
apoptosis102,105,107–112. It is often argued that the removal of damaged stem cells from a 
population has evolved in order to prevent the perpetuation of genomic instability within a 
tissue, which can lead to organ dysfunction or cancer, however this proposal is only 
theoretical.  ES cells are primed to apoptose by constitutively active Bax105,113 but do not 
require the upstream apoptotic regulator p53 102, which is insufficiently translocated to the 
nucleus in ES cells99,102.  The absence of a G1 checkpoint may contribute to the 
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sensitivity of ES cells to DNA damage, as restoration of the G1 checkpoint through Chk2 
overexpression was able to reduce IR-induced apoptosis in ES cells99,106. While p53 may 
not be directly related to ES cell apoptosis, p53 can alternatively induce differentiation 
following DNA damage by blocking expression of the pluripotency gene Nanog114 . 
Neural stem cells have also been shown to cease dividing and differentiate following 
DNA damage110. 
 
Tissue-specific stem cells vary in their radiation responses both across different tissues 
and among different populations within a particular niche. While the radiosensitivity of 
individually labeled neural stem cells in vivo has not been investigated, numerous reports 
have observed cell death and reduced proliferation of neural precursors within 
hippocampal regions of neurogenesis115–120.  Intestinal crypt stem cells also readily 
undergo IR-induced apoptosis121,122, in contrast with stem cells of the colon123.  The 
intestine is now believed to contain multiple stem cell populations and lineages 
however124–126, each with varying radiosensitivities127,128. While testicular stem cell loss 
has long been associated with infertility after radiation exposure129, labeled 
spermatogonial stem cells have in fact been shown to be radioresistant while adjacent 
nom-stem spermatogonia undergo IR-induced apoptosis130.  Stem cells within multiple 
tissue niches of skin have demonstrated radioresistance131,132, although the hair follicle 
niche may contain differentially regulated stem cell populations133 similar to intestinal 
crypts. Mesenchymal stem cells from bone marrow represent another radioresistant stem 
cell population134, while the relative radiosensitivity of hematopoietic stem cells appears 
to be species-dependent135–137. While certain characteristics are clearly conserved 
among all stem cell populations, it is apparent that stem cell radiation responses are 
highly context-dependent. 
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1.4.3.2 DNA Damage Response and DNA Repair 
Despite the apoptotic responses of many stem cell populations in response to DNA 
damage, most studies report rapid and efficient DNA repair capabilities in stem cells. ES 
cells are very efficient at mismatch repair, which is important for fixing base mis-
incorporation and other nucleotide base errors during DNA replication and may account 
for their low mutation rate. Limited studies suggest enhanced base excision repair in ES 
cells due to elevated expression of repair proteins, which reverses chemical modifications 
to DNA as well as single-strand breaks105. ES cells are however sensitive to UV-induced 
damage, with disagreement among the literature concerning their capacity for nucleotide 
excision repair of UV-induced lesions105,112,138. There is a great deal of conflicting 
information concerning repair of DSBs in ES cells. The majority of studies observed that 
both ES and neural stem cells show efficient repair of DSBs104,109,139–142. These stem cells 
predominantly repair DNA damage through homologous recombination due to their short 
G1 and elevated expression of repair factors143–147, however efficient NHEJ139,148,149 also 
contributes to their DNA repair efficiency. In agreement with these studies, robust DDR 
induction has also been shown in cultured embryonic and neural stem 
cells101,109,111,144,150,151. Despite strong evidence for efficient DDR signaling and DNA 
repair in stem cells, multiple studies also report that stem cells exhibit reduced DNA 
repair capacity. Differences appear to exist between mouse and human stem cells107; in 
fact one study found murine but not human ES cells to be deficient in repairing DNA 
breaks152. Murine induced pluripotent stem cells have also been found to exhibit 
inadequate H2AX phosphorylation and DNA repair153, and one of the few studies to 
actually compare stem cells with isogenic progeny observed that ES cells were less 
efficient at both induction and resolution of γH2AX foci154. Unirradiated ES cell lines 
exhibit high basal γH2AX which is believed to be important for regulating self-
renewal155,156, but this basal γH2AX appears to be independent of DDR signaling157. 
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The molecular signaling occurring within tissue stem cells in response to DNA damage is 
sometimes contradictory with their overall radiosensitivity. DDR foci have been observed 
in intestinal crypt stem cells158,159 despite the presence of IR-induced apoptosis in those 
same cells. Similarly, while spermatogonial stem cells of testis were shown to be 
radioresistant, they fail to display γH2AX or MDC1 foci correlating with reduced DNA 
repair based on 53BP1 foci resolution130. The DDR has not been well-detailed in neural 
stem cells in vivo, as previous studies have investigated the DDR principally within 
developmental contexts103,160 without the use of stem cell markers. Limited evidence from 
existing studies actually shows enhanced DDR foci and anti-apoptotic protein 
expression103, in contrast with radiosensitivity data from other publications. Both 
mesenchymal134,161 and hair follicle132 stem cells show elevated DDR and DNA repair 
capacity in agreement with their radiosensitivity data, and HSC molecular radiation 
responses were again species-dependent135–137.   
   
1.5  DNA DAMAGE-RESPONSIVE HISTONE MODIFICATIONS 
DNA damage induces substantial changes in chromatin, both globally and around DNA break sites.  
Specific histone modifications may play a role in all aspects of DNA repair, including controlling access of 
repair factors to DNA, signaling through the DNA Damage Response, transcriptional repression and 
reassembly of chromatin following repair162–164. Numerous histone modifications have been identified that 
are either beneficial or detrimental toward DNA repair signaling, and I will focus on a few relevant for this 
study. 
 
 1.5.1 H2AX S139 
Histone H2AX is phosphorylated by ATM at serine 139 (S139) to create γH2AX as part of the 
DNA Damage Response67, serving as a docking site for downstream DDR signaling and 
promoting DNA repair. While γH2AX foci around DSBs is the primary function of H2AX S139 
phosphorylation, pan-nuclear H2AX S139 phosphorylation (H2AX-pS139) has been observed in 
response to both DNA damaging agents and other stimuli165,166. This pan-nuclear H2AX-pS139 
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has been attributed to diffusion of DDR factors, creation of small DNA fragments, global 
chromatin changes, viral infection and apoptosis in various contexts.  Apoptotic H2AX-S139 
forms a ring or pan-nuclear stain around the nucleus following induction of apoptosis.  Reports 
vary in reporting whether the PIKK proteins ATM and DNA-PKcs55 or the apoptotic factors 
MST151,57 and JNK54  are responsible for apoptotic H2AX-S139 phosphorylation.  H2AX-pS139 is 
required for DNA fragmentation and degradation at the end of apoptosis, likely acting through the 
recruitment of caspase-associated DNases51,54. H2AX-pS139 also interacts with AIF in order to 
degrade DNA as part of a programmed necrosis cell death pathway167. This apoptotic H2AX-
S139 does not include MDC1 or 53BP1 and is associated with inhibition of DDR amplification due 
to inactivating caspase-mediated cleavage of MDC1165,168. 
 
1.5.2 H2AX Y142 
The tyrosine 142 (Y142) residue on histone H2AX is also an important regulator of molecular 
responses to DNA damage.  H2AX-Y142 phosphorylation (H2AX-pY142) is mediated by WSTF 
kinase169 and EYA phosphatase170. H2AX-pY142 is inversely regulated with H2AX-pS139, as 
Y142 is phosphorylated under basal conditions and is dephosphorylated following DNA damage, 
paralleling γH2AX induction169,170.  Basal H2AX-pY142 is necessary for maintenance of normal 
DDR signaling in response to DNA damage169, whereas removal of Y142 phosphorylation is 
required for MDC1 binding to γH2AX and subsequent DDR amplification. In addition to blocking 
DNA repair signaling, the presence of H2AX-pY142 following induction of DSBs instead recruits 
apoptotic factors, leading to induction of apoptosis through JNK170.  The structure of the Y142 
residue itself also appears to be important for normal DDR signaling and radiosensitivity171,172. 
Additionally, both IR and drug-induced apoptosis may involve co-regulation of the H2AX S139 
and Y142 residues172,173. 
 
1.5.3 H3K56ac 
Histone 3 lysine 56 acetylation (H3K56ac) has been identified as an important DNA damage-
responsive histone modification that may play a substantial role in DDR signaling and chromatin 
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structure around DNA breaks.  Several studies have assessed global changes in H3K56ac levels 
in response to genotoxic stress, with contradictory results concerning whether levels increase174–
176 or decrease177–179. In yeast, H3K56ac promotes deposition of H3 histones on to chromatin 
during DNA replication and following repair180–183, promoting genomic stability.  H3K56ac has also 
been shown to be enhanced during S phase and beneficial for genomic stability in mammals184. 
In contrast, H3K56ac is reduced at DSB sites and constitutively enhanced H3K56ac may impair 
NHEJ and break-induced replication by blocking resolution of repair factor foci177,185.  Temporal 
evidence suggests that these contrasting results are due to a biphasic response of H3K56ac 
exhibits a biphasic response following DNA damage177,186.  Proper initiation of DDR signaling and 
DNA repair factor recruitment may therefore require initial reduction of H3K56ac levels followed 
by rapid restoration of H3K56ac to restore the basal chromatin configuration state and complete 
DNA repair177,186. 
  
1.5.3.1 Regulators of H3K56ac 
Several acetyltransferases and deacetylases have been associated with H3K56ac. In 
yeast, H3K56ac is acetylated by Rtt109 and deacetylated by the surtuin family homologs 
hybrid sterility (Hst)3 and Hst4181,183,187. H3K56ac regulation appears to me more complex 
in mammalian cells, as both GCN5178 and CREB-binding protein (CBP)/p300174,175 have 
been identified as relevant acetyltransferases. Conserved in both yeast and mammalian 
cells is the requirement of the histone chaperone Anti-silencing function protein 1 (Asf1) 
(ASF1A in mammals)174,181,183,186,188, which directs CBP/p300 to chromatin and promotes 
their interaction with H3K56ac. Several deacetylases for H3K56 have been identified as 
well in human cells. In addition to histone deacetylase (HDAC)1 and HDAC2177 multiple 
sirtuin family members have been associated with H3K56 deacetylation, namely sirtuin 
(SIRT)1 and SIRT2 174,184 as well as SIRT6 189. 
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 1.5.3.1.1 p300/CBP 
p300 and CBP are closely related nuclear proteins. In addition to their role as  
histone acetyltransferases, p300 and CBP also act as transcriptional coactivators 
by directing assembly of transcriptional machinery at promoter regions190,191. 
Genomic localization of p300 binding elucidated that p300 is predominantly 
recruited to pluripotency genes in ES cells192, mirroring the enrichment of 
H3K56ac at pluripotency gene promoters93,94. p300 is also necessary for proper 
regulation of ES differentiation193. p300 and CBP also play a role in the induction 
of apoptosis, primarily through their regulation of p53. p300 binding to p53 may 
promote its degradation under basal conditions, but upon cellular stress 
p300/CBP acetylation of p53 promotes p53 transcriptional activation of target 
genes190,194–196. Additionally, p300 and CBP are also mutated in many cancers197 
and p300 (but not CBP) loss has been shown to impair apoptosis in culture 
cells198. 
    
1.6  PROJECT SUMMARY 
The goals of my thesis research were to identify the molecular basis for stem cell radiation responses.  
Unintended sequelae resulting from radiation therapy have been attributed to the loss of tissue 
regenerative potential. While there are many mechanisms of radiation-induced normal tissue injury, my 
project exclusively investigated stem cell dropout, which affects all actively proliferating and regenerative 
tissues. Destruction of stem cell compartments leads to progressive loss of tissue function and integrity 
due to dysregulation of normal tissue turnover as differentiated functional tissue compartments are unable 
to be replenished over time. The clinical motivation underlying this dissertation is to understand the 
cellular targets of radiation damage and the molecular mechanisms underlying this radiosensitivity. My 
thesis work began by confirming that only stem cells undergo programmed cell death following exposure 
to therapeutic IR doses, while surrounding differentiated cells within the niche are radioresistant. The 
primary focus of my project was then to elucidate the molecular mechanisms responsible for this 
differential radiosensitivity among stem and differentiated cells. My studies focus on differences in DNA 
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Damage Response signaling and regulation of histone modifications that contribute to stem cell IR 
hypersensitivity. 
 
Since stem cells are responsible for generating all differentiated cell types of a tissue, maintaining 
genomic integrity is of utmost importance to ensure that mutations are not passed on to future progeny. 
Identifying the details of stem cell responses to DNA damage has therefore been a popular research 
topic. However, the vast majority of studies previously performed only focused on a particular stem cell 
model, either in culture or within a specific tissue niche. This precludes identifying broadly applicable 
mechanisms concerning stem cell radiation responses that are conserved across multiple tissue types.  
We therefore utilized multiple clinically relevant stem cell niches in order to identify molecular 
mechanisms responsible for IR-induced normal tissue injury. We assessed cell death and DDR signaling 
in the dentate gyrus of brain, seminiferous tubules in testis, intestinal crypts and hair follicles. There has 
also been a stark lack of emphasis in the literature on the use of primary, early passage culture cells.  
Stem cells can rapidly evolve genomic and epigenomic changes upon culturing199,200 that may result in 
modified stem cell molecular responses to DNA damage, so avoiding extended passage of cells is 
essential. The majority of published studies also do not compare cultured stem cells with directly 
differentiated, isogenic progeny. This introduces additional complications such as strain variation, cell 
type-specific differences and additional culture artifacts from the use of established cell lines. We wanted 
to study stem cell radioresponses together both in vivo and in culture, so we took great efforts to establish 
primary culture models that recapitulate observed in vivo phenomena. We established two culture 
models, murine embryonic stem cells (ES) and neural stem cells (NS). ES cells were primarily purchased 
from American Type Culture Collection (ATCC) or the Washington University Murine Embryonic Stem 
Cell Core for convenience, but are originally isolated from the inner cell mass of 4.5 day old blastocysts, 
while we isolate neural stem cells ourselves from the hippocampus of P0-P2 neonatal mice. ES and NS 
cells are non-specifically differentiated by removal of LIF or EGF/FGF, respectively, from media 
conditions (Fig. 1.2). Differentiated ES cells (ED) take on a fibroblast-like appearance while differentiated 
NS cells (ND) are mixed but biased towards astrocytic differentiation due to supplementation with serum 
to promote proliferation201. We utilized non-targeted differentiation because we are interested in the effect 
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of merely losing stemness as opposed to any lineage-specific phenotypes. Through establishing this 
culture system, we have been able to more accurately assess the role of differentiation state in dictating 
radiation responses. 
 
The first chapter of my thesis analyzes the relative radiosensitivity of stem cells as compared to their 
differentiated progeny. The remaining two chapters examine the molecular mechanisms underlying the 
observed differential radiosensitivity between stem and differentiated cells. We first compared induction of 
the DDR and DNA repair between stem and differentiated cells in order to determine whether inhibited 
signaling responses to DNA damage could contribute to increased radiosensitivity. Since the purpose of 
our experimental design was to discover conserved IR-phenotypes linked specifically to differentiation 
status, we wished to examine molecular regulators of stemness that could also potentially influence 
radiosensitivity or the DDR. Cell type and differentiation status are determined by unique transcriptional 
programs that are controlled by specific combinations of histone modifications202.  In addition to 
controlling binding of transcription factors to DNA, histone modifications can also regulate access of 
repair factors. Differentiation status, epigenetic profiles and DNA repair signaling are thus all related (Fig. 
1.3). My thesis attempts to define the connections between these features and how they can characterize 
cellular radiosensitivity. A better understanding of the molecular mechanisms underlying radiation 
responses of stem and differentiated cells will promote future targeted therapies for reducing detrimental 
sequelae in patients. 
 
 25 
 
 
Figure 1.2. Primary stem cell culture models utilized in this study. 
Figure 1.3. The interrelatedness of the DDR, differentiation state and epigenetics in 
controlling cellular radiosensitivity. 
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CHAPTER 2 
Stem Cells are Radiosensitive in Contrast with 
their Differentiated Progeny 
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2.1 ABSTRACT 
The exposure of normal tissue to ionizing radiation (IR) during radiotherapy for cancer treatment leads to 
undesired sequelae. Normal tissue injury resulting from ionizing radiation (IR) during cancer radiotherapy 
has been in part attributed to reduced regenerative capacity of tissues. Utilizing multiple in vivo tissue 
niches and culture models, we demonstrate that normal stem cells are highly radiosensitive while their 
isogenic differentiated progeny are radioresistant. Stem cell apoptosis is associated with differential 
induction of pro- and anti-apoptotic proteins, occurs in all cell cycle phases and is independent of 
proliferation status. By determining that normal tissue injury involves loss of individual stem cells within 
their respective niches and not the entire stem cell compartment, this work has identified potential targets 
for future therapeutic intervention.  By inhibiting these apoptotic pathways in stem cells specifically, 
strategies may be developed for minimizing side effects from radiation therapy.  
 
2.2 METHODS 
2.2.1 Cell Lines and Differentiation 
Karyotypically normal early passage ES cells (EDJ22) were obtained from the Murine Embryonic 
Stem Cell Core of Siteman Cancer Center at Washington University. ES cells were grown on 
gelatin-coated plates, and maintained in stem cell culture media containing Knockout DMEM, 10 
ng/ml leukemia inhibitory factor (LIF), 2 mM L-glutamine (Invitrogen), non-essential amino acids 
MEM (Corning), 15 % FBS, 0.2 % β-mercaptoethanol, 1 % penicillin/streptomycin and 40 μg/ml 
gentamicin (Invitrogen) and not used for more than 5 passages. Cells were passaged every 2 
days using 0.05%Trypsin/0.53mM EDTA (Corning). Differentiated cells (ED) were generated by 
culturing ES cells in media lacking LIF for 5-7 days. Neural stem (NS) cells were isolated from 
dentate gyri of late stage mouse embryos (E15-E18) or new born pups (P0-P1) and cultured in 
neural stem cell media containing Knockout DMEM/F-12 containing 15 mM Hepes (Stem Cell 
Technologies) with 1% N2 supplement, 2 % B27 supplement, 10ng/ml bFGF, 20ng /ml EGF, 1 % 
penicillin/streptomycin and 40 μg/ml gentamicin (Invitrogen) and thereafter differentiated in the 
absence of EGF/FGF growth factors with addition of 10% FBS (Hyclone) for ~7 days.  
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2.2.2 Animal Models 
Mouse strain C57BL/6 was used for all animal studies.  Adult 6-8 week old males were utilized for 
harvest of brain, intestine, skin and testis for sectioning.  For breeding, 1-6 month old male and 
female mice of similar age were allowed to mate continuously, with pregnant females isolated 
independently before giving birth.  P0-P2 mouse pups were sacrificed by rapid decapitation prior 
to dissection for neural stem cell isolation.  Procedures for all studies were been approved by the 
Animal Studies Committee at Washington University Medical Center. 
 
2.2.3 Antibodies 
Details of the antibodies used in this work are described in Table 2.1. 
 
 
Table 2.1. Antibody Information Table 
   Protein Target Species Company Catalog # Assay Conditions 
Bax mouse Santa Cruz sc-7480 WB 1:250 in milk 
Bcl2 rabbit Cell Signaling #2870 WB 1:100 in milk 
BrdU (AlexaFluor 488 
conjugated) mouse Invitrogen B35139 FACS 1:20 
cleaved Caspase-3 rabbit Cell Signaling #9664 IHC-F, WB 
1:500, 1:500 
in milk 
Cleaved PARP mouse BD Biosciences 51-9000017 IHC-F 1:100 
Ki67 rabbit NeoMarkers RB-1510-P0 IHC-F 1:100 
Lin28 rabbit Abcam ab46020 WB 1:1000 in milk 
Nanog rabbit Abcam ab80892 WB 1:1000 in milk 
Oct4 rabbit Abcam ab19857 IF, IHC-F 1:200, 1:200 
PARP rabbit Cell Signaling #9542 WB 1:2000 in milk 
PCNA mouse Millipore NA-03 IHC-F 1:100 
Pro Caspase-3 rabbit Cell Signaling #9665 WB 1:1000 
Sox2 rabbit Abcam ab7959 IHC-F 1:100 
Sox2 mouse Abcam ab79351 IF, IHC-F 1:200, 1:100 
SSEA1 mouse Abcam ab16285 IHC-F 1:100 
GAPDH mouse Sigma Aldrich G8795 WB 
1:100,000 in 
milk 
FITC-conjugated anti-
rabbit donkey Vector FI-1000 IF, IHC-F 1:100 
FITC-conjugated anti-
mouse horse Vector FI-2000 IF, IHC-F 1:100 
Texas Red-conjugated 
anti-mouse horse Vector TI-2000 IF, IHC-F 1:100 
Texas Red-conjugated 
anti-rabbit donkey Vector TI-1000 IF, IHC-F 1:100 
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HRP-conjugated anti-
mouse rabbit Sigma Aldrich A9044 WB 1:5000 in milk 
HRP-conjugated anti-
rabbit goat Sigma Aldrich A0545 WB 1:5000 in milk 
 
 
2.2.4 X-Ray Irradiation and Tissue Sectioning 
Cells and animals were irradiated in the RS-2000 Biological Research Irradiator (Rad-Source) at 
room temperature, with mock/control irradiated samples brought into the room to simulate the 
reduction in ambient temperature and account for any stress imparted by the travel. Cells were 
always placed within the central circle directly under the x-ray source to maintain consistency in 
dose between samples. Animals were anesthetized with isofluorane and placed on their back in 
the machine for whole-body irradiation to properly expose all tissues of interest to the x-ray 
source.  Accuracy of all doses was confirmed by dosimeter probe. Both cells and animals were 
randomly assigned to individual timepoints or sham-irradiation controls.  
 
Following irradiation, mice were sacrificed at specific timepoints by CO2 asphyxiation and cervical 
dislocation. Organs were harvested, placed in OCT media and frozen in liquid nitrogen. Frozen 
tissues were sectioned on a cryostat machine at a thickness of 10 μm, placed onto adhesive 
slides and stored at -80oC.  
 
2.2.5 Apoptosis Assays (TUNEL, Annexin V, Annexin XII/ pSIVA) 
Apoptosis in tissue sections (staining and microscopy) and cultured cells (flowcytometry), were 
analyzed using various assays such as TUNEL, Annexin V, and Annexin XII following 
manufacturer’s protocol. In cultured cells, APO-BrdU TUNEL Assay kit with Alexa Fluor 488 Anti-
Brdu (Invitrogen) was used for TUNEL assay, Annexin- V FITC detection kit (BD Pharmingen) 
was used for Annexin V staining, and GLO pSIVA-IANBD Apoptosis / Viability Flow Kit (Imgenex) 
for Annexin XII staining. 10,000 cells were counted for flow cytometry analysis. TUNEL staining 
on tissue sections was performed with the DeadEND fluorescent TUNEL system (Promega).  
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2.2.6 Western blotting 
Cellular protein lysates were collected in RIPA buffer, electrophoresed on 4-15 % Tris-Glycine 
polyacrylamide gels (BioRad), transferred onto PVDF membranes and after blocking with 5 % 
BSA or milk in TBS-T incubated overnight at 4 oC with various primary antibodies followed by 
secondary antibody incubation. Super ECL (GE/Pierce) was used as substrate for detection on 
autoradiography film or ChemiDoc MP digital system (BioRad).  
 
2.2.7 Immunofluorescent Staining 
Cryosections were fixed in 4 % formaldehyde, permeabilized with 0.2 % Triton-X 100 (Sigma), 
blocked in 2 % BSA in PBS, probed using primary antibodies and detected using 5 μg/ml 
secondary antibodies labeled with FITC or TexasRed (Vector Labs). After mounting in 
Vectashield mounting media containing DAPI (Vector Labs), microscopic observations, scoring 
and quantifications were done and fluorescent images were taken.   
 
Cells were similarly fixed in 4% formaldehyde and permeabilized with 0.2% Triton-X 100 before 
blocking in 2 % BSA and antibody incubation. For double-color staining, primary antibodies were 
incubated together for 1h at 37oC followed by wash and incubation with fluorescently-tagged 
secondary antibodies for 30 min at 37oC.  
 
2.2.8 Clonogenic Survival Assay 
Cells were used in a colony formation assay to measure cell survival after IR treatment using 
standard protocols. Cells were plated, irradiated at various doses and allowed to grow for 7 to 14 
days. Any colonies formed were fixed and stained with crystal violet (Sigma). The number of 
colonies (with >50 cells) per dish was counted, and the surviving fractions were calculated as the 
ratio of the plating efficiencies of treated cells to untreated cells. 
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2.2.9 Neutral Comet Assay 
To assess and quantify DNA breaks and apoptotic fragmentation of DNA, neutral comet assays 
were performed using CometSlide assay kits (Trevigen). Cells were irradiated with 6 Gy, lysed, 
electrophoresed in agarose in TAE buffer and stained with SYBR Green (Trevigen). Olive 
moment of the comets was calculated by multiplying the percentage of DNA in the tail by the 
displacement between the means of the head and tail distributions. CometScore™ Version 1.5 
(TriTek) was used to calculate Olive Moment. A total of 50–75 comets were scored and analyzed 
per sample in each experiment with each series of timepoints repeated at least three independent 
times as both biological and technical replicates.  Individual comets were randomly selected for 
scoring from similar regions of the slide in all samples. Outliers were eliminated that fell greater 
than 1.5 standard deviations from the mean. Data from all samples was approximately normally 
distributed, and the standard deviation between samples within the same experiment was similar. 
Samples were excluded from analysis only due to technical errors from the assay or cells being 
visibly unhealthy. 
 
2.2.10 Cell Cycle Analysis 
For phase-specificity of apoptosis, live cells were incubated for 1h at 37oC with Vibrant FAM 
Caspase-3 and 7 FLICA reagent (Invitrogen). Cells were subsequently fixed for 15min with 4% 
formaldehyde at 4oC prior to overnight ethanol fixation at -20oC in order to preserve cytoplasmic 
contents during ethanol permabolization. Fixed cells were subsequently incubated with RNase 
and propidium iodide followed by flow cytometric analysis. Total and apoptotic populations were 
gated for each cell cycle phase, and the ratio of apoptotic to total cells within each phase was 
obtained. 
 
ES and ED cells were incubated with 20μM BrdU (Sigma) for 30min, washed 2 times and chased 
for various timepoints to allow cell cycle progression. Cells were then fixed overnight in ethanol at 
-20oC, incubated with RNase and propidium iodide, and analyzed by flow cytometry.  For in vivo 
BrdU incorporation, 100ul of 10mg/ml BrdU was injected intraperitoneally. Mice were sacrificed 
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after 72h, and skin sections were isolated for frozen sectioning. BrdU incorporation into skin was 
detected by immunofluorescence. 
 
 2.2.11 Viability Assay 
Cells were plated in equal numbers onto dishes and were either allowed to grow for 24-48hr (ES) 
or differentiated for 3-4 days. Cells were then irradiated with 6Gy and incubated for the specified 
period of time. Cells were harvested by trypsinization into single-cell suspensions and counted on 
the Vi-Cell Viability Analyzer (Beckman Coulter) by trypan blue incorporation. At least 100,000 
cells were counted per sample. 
 
2.2.12 Microscopy and Image Processing 
Micrographs were captured utilizing MetaSystems ISIS imaging software on Zeiss Axioplan2 
microscope or ZEN software on Zeiss LSM510 confocal microscope with the 20x, 63x or 100x 
objective lenses. Minimal threshold and contrast manipulation was performed equally across 
entire images. Controls were processed equally with treated samples. Adobe Photoshop CS3 
software was utilized for composing the collages of multiple pictures and labeling micrographs 
and Immunoblots in individual layers.  
 
2.2.13 Statistical Analysis 
A ‘two-tailed’ Student's t-test was used to calculate the statistical significance of the observed 
differences. In all cases, differences were considered statistically significant when  p<0.05. 
Unless otherwise indicated, values represent mean ± SEM. 
 
 
2.3 INTRODUCTION 
Radiation therapy utilizes ionizing radiation (IR) to produce lethal DNA double-strand breaks (DSBs) in 
cancer cells; however detrimental side effects often result from unintended damage to normal tissue1. 
Patients undergoing radiotherapy experience acute and chronic sequelae such as hair loss, skin 
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regeneration defects, erosion of intestinal epithelium, malabsorption, hematopoietic anomalies, infertility, 
and neurocognitive impairments1–5. Normal tissue injury following radiotherapy has been attributed to the 
loss of regenerative capacity in stem cell compartments6,7, however the molecular details of normal stem 
cell radiosensitivity remain unclear.  
 
Ionizing radiation (IR)-induced cell death is caused by DNA damage, especially complex DNA double 
strand breaks8. Under tolerable ranges, damaged DNA is efficiently repaired, but if beyond the repairable 
state or in the event that the DNA repair process is hampered, cells either stop dividing or undergo 
programmed cell death9. Cells vary in their response to DNA damage depending on the cell type, 
differentiation status, proliferation state and cell cycle stage10. An improved understanding of cellular 
radiation responses is essential for the development of strategies to protect normal tissue during 
radiotherapy. However, despite  indications for stem cells playing a role in normal tissue injury resulting 
from radiotherapy11–13 studies on the relative radiosensitivity of stem cells remain debatable at 
experimental and molecular mechanistic levels. While many investigators acknowledge high 
radiosensitivity in stem cells14–19 other reports show relative radioresistance20–22. There is, however, a lack 
of direct comparison of differential radiation responses in stem and differentiated cells in vivo and of stem 
cells with their isogenic progeny in cell culture models. Moreover, the usage of primary, early passage 
cells could avoid possible culture artifacts. Further, the molecular mechanisms of differential 
radiosensitivities must be elucidated to develop therapeutics that minimize stem cell drop-out and 
resulting radiation damage to the normal tissue.  
 
We demonstrate that stem cells are hypersensitive to relatively low dose IR both in vivo in normal stem 
niches of various tissues as well as in karyotypically normal, early passage primary mouse embryonic and 
neural stem cells as compared to their isogenic differentiated progeny. IR-induced apoptosis in stem cells 
occurs within few hours after irradiation and involves the action of various apoptotic factors. This 
apoptotsis is broadly distributed across the cell cycle in stem cells, while differentiated cells apoptose 
primarily during G2/M phase. The observed differential radiosensitivity between stem and differentiated 
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cells is not due to enhanced proliferation in stem cells, suggesting that enhanced radiosensitivity is 
inherent to an undifferentiated cell state. 
 
2.4 RESULTS 
2.4.1 Normal stem cells in vivo are radiation hypersensitive while surrounding non-stem 
cells are relatively radioresistant 
To analyze the radiosensitivity of stem cells compared to differentiated non-stem cells in vivo, 
C57BL/6 male mice were whole-body irradiated and observed for apoptosis in the stem cell 
niches of the subgranular (SGZ) and subventricular zones (SVZ) in brain, hair follicle bulge in 
skin, intestinal crypt and seminiferous tubules of testis. The selected stem cell compartments are 
located within four clinically relevant tissues that each exhibit deleterious consequences from 
radiation therapy. A dose curve was performed from 0-10Gy and apoptosis was observed in each 
niche relative to labeled stem cells at 6h, 12, 24h and 48h following irradiation. Apoptosis was 
exclusive to individually stem cells within all niches at lower doses as indicated by various 
markers, and almost every stem cell present was undergoing cell death at 6Gy (Fig. 2.1, 2.2).  
Apoptosis was not observed in any unirradiated samples (Fig. 2.2, 2.3). While apoptosis was 
observed in stem cells following exposures to as low as 2Gy IR, only minimal apoptosis was seen 
in differentiated cells at doses 8Gy and above. These data establish that stem and differentiated 
cells exhibit varying thresholds for responding to DNA damage.   
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Figure 2.2. Dose curve of IR-induced apoptosis among stem and non-stem cells in vivo. The 
percentage of apoptotic stem and non-stem cells was measured at 12h after incremental irradiation 
doses. Stem and non-stem cells were scored within the entire intestinal crypt and proliferative zone of 
the villus. No apoptosis was observed in the terminally differentiated upper villus. N=3 (combined 
counting of 3 sections each from 3 independent mice). Error bars indicate SEM. 
 
Figure 2.1. IR-induced apoptosis is exlusive to stem cells in vivo. Immunofluorescence co-staining of 
stem cell markers (red; Sox2, Stage-specific embryonic antigen 1 [SSEA1], Oct4) and apoptosis markers 
(green; c-PARP, CC-3,) in tissue niches 12h following 6Gy whole body irradiation. Green and red arrows 
indicate cells positive for both stem cell marker and apoptosis marker. DAPI=DNA. SVZ=subventricular 
zone; SGZ=subgranular zone. CC-3=cleaved caspase-3; c-PARP=cleaved Poly ADP-ribose polymerase 
(PARP). White scale bars, 10µm. 
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Figure 2.3. In vivo sham irradiation apoptosis negative controls. Immunofluorescence co-staining of 
stem cell markers (red; Sox2, SSEA1, Oct4) and apoptosis markers (green; c-PARP, CC-3, TUNEL) in 
tissue niches 12h following 0Gy sham whole body irradiation. DAPI=DNA. CC-3=cleaved caspase-3; c-
PARP=cleaved PARP. White scale bars, 10µm. 
  
 
2.4.2 Radiation hypersensitivity is recapitulated by primary embryonic and neuronal stem 
cells in culture 
We also established two sets of karyotypically normal, early passage, primary cell culture models 
in mouse embryonic stem cells (ES) and neural stem cells (NS) along with their isogenic 
differentiated non-stem counterparts (ED and ND, respectively). Both stem cell models were 
directly differentiated by passage in the absence of specific growth factors (Fig. 2.4 A-B). 
Radiation responses of stem cells could thus be assessed in parallel with their isogenic, recently 
differentiated progeny in order to compare outcomes. ES cells demonstrated a progressive linear 
decrease in viable cell number across multiple timepoints following 6Gy irradiation (Fig. 2.5). 
Significantly higher levels of apoptosis were detected in both cell culture models compared to 
their differentiated progeny following 6Gy IR (Fig. 2.6 A-C). Clonogenic survival curves confirmed 
logarithmic higher rates of cell killing in stem cells compared to non-stem cells at all doses, 
accounting for both cell death and senescence in measuring cellular replicative capacity following 
irradiation (Fig. 2.7). DNA fragmentation is among the final steps of apoptosis as the nucleus is 
degraded by caspases and DNases. As a further indicator of apoptosis, we utilized comet assays 
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Figure 2.4. Differentiation of stem cell culture models. (A) Bright field images and 
immunofluorescence staining for stem cell markers (green; Oct4, Sox2) demonstrating differentiation of 
ES cells into ED cells and NS cells into ND cells. DAPI=DNA. White scale bars, 10µm. (B) Western blots 
for stem cell markers on unirradiated ES, ED, NS and ND. GAPDH served as a loading control.  
to assess late-stage apoptotic DNA fragmentation.  Comet assays employed single-cell gel 
electrophoresis following irradiation and nuclear lysis. Differentiated cells displayed progressive 
reduction of DNA breaks over time following irradiation, whereas DNA breaks in stem cells starkly 
increased beginning at 8h post-IR consistent with apoptotic DNA fragmentation (Fig. 2.8 A-B). 
The apoptotic effectors of cleaved poly ADP-ribose polymerase (PARP) and caspase-3 were also 
detected exclusively in stem cells beginning 4h post-irradiation. Additionally, differential levels of 
pro- and anti-apoptotic Bcl-2 family member proteins were observed in stem and non-stem cells. 
Pro-apoptotic Bax was higher in ES cells and increased upon irradiation, while the anti-apoptotic 
Bcl-2 showed higher expression in ED cells (Fig. 3.9 A-B).  These results demonstrate that stem 
cells are substantially more radiosensitive than non-stem differentiated cells and readily undergo 
IR-induced cell death. 
 
 
 
 
 
 
 
50 
 
 
 
  
Figure 2.5. Differential viability of ES and ED cells following irradiation. ES and ED cells were 
irradiated with 6Gy during exponential growth and incubated for the indicated times prior to viability 
counting by trypan blue incorporation. N=3. Error bars indicate SEM. 
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Figure 2.6. Stem cells but not directly differentiated progeny undergo IR-induced apoptosis in 
culture. Flow cytometric analysis of apoptosis comparing ES and ED or NS and ND cells by (A) Annexin-
V, (B) Annexin-XII, and (C) TUNEL labeling following sham or 6Gy IR at indicated timepoints. N=3; * = p < 
0.05; ** = p < 0.01; otherwise not significant. 
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Figure 2.7. Clonogenic survival of cell culture models after various IR 
doses.  ES, ED, NS and ND cells were irradiated 6h after plating. N =3. 
Error bars indicate SEM. 
Figure 2.8. Neutral comet assay on cell culture models at late timepoints. Olive moments of (A) ES 
and ED or (B) NS and ND cell comet assay tails were quantified at different timepoints following sham or 
6Gy IR and normalized to the irradiated 0min timepoint to demonstrate apoptotic nuclear fragmentation in 
stem cells at late timepoints. N=3. Error bars indicate SEM. 
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2.4.3 Radiation hypersensitivity in stem cells is independent of proliferation status 
Since the Law of Bergonié and Tribondeau states that radiosensitivity is strongly correlated with 
proliferation rate 23, we examined whether the observed differential radiosensitivity between stem 
and non-stem cells was due to differences in proliferation status. ES and ED cells in culture were 
found to proliferate at similar rates as measured by BrdU pulse-chase (Fig 2.10), and Ki67 
staining identified both resting and proliferative cells among both the stem and non-stem cell 
populations in vivo (Fig. 2.11). Additionally, replicating cells within S phase were detected broadly 
throughout and surrounding unirradiated hair follicles by proliferating cell nuclear antigen (PCNA) 
staining (Fig. 2.12 A) and BrdU incorporation (Fig. 2.12 B). The relative ratio of proliferative vs. 
apoptotic stem cells was then quantified in the SGZ. While only about 30% of stem cells were 
proliferative, 75% of stem cells underwent apoptosis (Fig. 2.13 A). Stem cells in vivo were 
radiosensitive at low doses, while IR-induced apoptosis was only observed at 8Gy or higher 
among non-stem cells of the “proliferative zone” above the intestinal crypt (Fig. 2.2, 2.13 B). 
Figure 2.9. Western blots for apoptotic effectors.  ES and ED cells were collected at various 
time points following mock or 6Gy irradiation. GAPDH served as a loading control. Clvd casp 
3=cleaved caspase-3; Pro casp 3=Pro caspase-3.  
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Figure 2.10. BrdU pulse-chase profiles labeling cell cycle progression of unirradiated stem 
and non-stem cells. Timepoints indicate incubation time following removal of BrdU. Rectangles 
indicate the presence of G1, S, and G2 populations. 20,000 gated cells were counted for analysis. 
Terminally differentiated cells were highly radioresistant at all tested doses (Fig. 2.14). These 
data indicate that while proliferation status may affect radiosensitivity in non-stem cells, the 
hypersensitivity of stem cells to IR is an inherent property of their undifferentiated state. 
 
 
 
 
 
Figure 2.11. Proliferation status of stem and non-stem cells in vivo. Immunofluorescence co-
staining of proliferation marker Ki-67 (red) and stem cell marker SSEA1 (green) in unirradiated tissue 
niches. DAPI=DNA. Green arrows indicate stem cells, red arrows indicate proliferative cells. White scale 
bar, 10µm. 
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Figure 2.12. Proliferating cells exist both within and outside of the hair follicle bulge stem cell 
region. Immunofluorescence staining of (A) S-phase marker PCNA (red) and (B) BrdU (green) in 
unirradiated skin. DAPI=DNA. White scale bars, 10μm.  
Figure 2.13. Apoptosis relative to proliferation status of stem and non-stem cells in 
vivo. (A) The fraction of Ki-67 positive (proliferative) or TUNEL positive (apoptotic) cells 
among Sox2+ stem cells was quantified across the dentate gyrus at 6h following 6Gy 
irradiation. N=3 (combined counting from  7 gyri sections each from 3 separate mice). ** = p < 
0.01. (B) Immunofluorescence co-staining of SSEA1 (red) and CC-3, (red) in intestinal crypt 
and the proliferative lower villus 12h following 10Gy whole body irradiation. Green and red 
arrows indicate cells positive for both stem cell marker and apoptosis marker. DAPI=DNA. 
CC-3 = cleaved caspase-3. White scale bar, 10µm. 
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2.4.4 IR-induced apoptosis of stem cells is more widely distributed throughout the cell 
cycle  
We also investigated potential differences between stem and non-stem cells in radiosensitivity 
across the cell cycle phases. As expected, substantially higher IR-induced apoptosis was 
detected in stem cells overall compared to their differentiated progeny (Fig. 2.15).  The “apoptotic 
ratio” was then quantified throughout each cell cycle phase (Fig. 2.15 inserts) by comparing the 
relative percentage of apoptotic cells present in each phase relative to the overall proportion of 
the total cell population within that phase. Apoptotic ratios were thus normalized to the overall cell 
cycle distribution. Ratios above or below 1.0 indicated increased or reduced propensity to 
undergo apoptosis in that phase, respectively. ED cells displayed a strongly increasing apoptotic 
Figure 2.14. Model of radiosensitivity relative to proliferation status within the intestinal crypt 
and villus. All intestinal crypt stem cells are radiosensitive at low doses, while only proliferative 
progenitors of the lower villus display any apoptosis among differentiated cell population. 
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ratio within the G2/M population over time post-irradiation, while in G1 the ratio remained low. In 
contrast, ES cells apoptosed across all phases of the cell cycle, displaying a 2-3 times higher 
apoptotic ratio in G1 as compared to the ED cells.  
 
 
 
2.5 DISCUSSION 
During radiation therapy patients often suffer from normal tissue injury, limiting the dose that can be used 
on the tumor. Normal tissue injury as a result of radiation therapy1 has long been associated with the loss 
of regenerative stem cell compartments in the affected tissues6, resulting in clinical consequences such 
as cognitive impairment24, infertility25, intestinal epithelial erosion4,26 and hair loss5. Unfortunately, our 
Figure 2.15. Differentially distributed radiosensitivity across the cell cycle in stem and 
non-stem cells. ES and ED cells were co-stained with FLICA apoptosis marker and propidium 
iodide at 8h and 12h after sham or 6Gy IR. The ratio of apoptotic cells (red) relative to total 
cells (blue) in each cell cycle phase was calculated to obtain the apoptotic ratio (inserted 
graphs). Ratios above or below 1.0 indicate increased or decreased apoptosis, respectively, 
within that phase when normalized to the phase distribution of the total cell population. 
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understanding of stem cell radiation responses remains incomplete. While several reports suggest high 
radiosensitivity of stem cells compared to differentiated cells in the intestine 27–29 and brain17,30 as well as 
in ES cells19,31, others have reported relative resistance of stem cells within testis 22 and skin21. Such 
ambiguity may be due to the presence of different stem cell populations within these tissue compartments 
32,33, heterogeneity among tissue types, uncertainty about the true detection/ location of stem cells within 
these niches 34, or potentially even from developmental variation within stem cell compartments . 
Moreover, the use of different cell lines as well as prolonged culturing of cells, which possibly influences 
the cells’ radiation response, might contribute to the heterogeneity between studies35. Thus in this study 
we chose to analyze early passages of primary stem cells along with multiple in vivo adult stem cell tissue 
niches as compared to their isogenic, directly differentiated progeny. We observed stem cell-specific 
radiosensitivity in all four analyzed tissue niches and both culture models, suggesting that IR 
hypersensitivity is a common phenomenon among different types of stem cells.  
 
Stem cell-specific IR-induced apoptosis is detected in stem cell niches in vivo at 2Gy and above, while 
adjacent differentiated cells are radioresistant below 8-10Gy. These observations suggest the likely 
existence of a threshold of DNA damage above which cells are unable to repair, as has been previously 
suggested36. This threshold probably exists for various cell types in vivo and is likely defined by the 
specifics of a cell’s molecular response to DNA damage. The IR-induced apoptosis-prone phenotype of 
stem cells and loss of function of apoptosis upon differentiation was confirmed by clonogenic survival 
assay and comet assay. Further, ES cells showed higher expression and activation of pro-apoptotic Bax, 
in agreement with studies showing constitutively higher levels of Bax in human embryonic stem cells37. 
ES cells displayed lower expression of anti-apoptotic Bcl-2, which correlates with priming of stem cells to 
apoptose in response to DNA damage as has been previously published for human embryonic stem 
cells31.  
 
It has long been established that cellular proliferation rate directly correlates with radiosensitivity 23. 
However, highly proliferative tissues may merely elicit the fastest response to radiation and not 
necessarily the greater overall radiosensitivity38. When combined with the predominant use of rapidly 
dividing culture models for studying stem cell biology, there remains uncertainty as to whether stem cell 
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hypersensitivity is an inherent property of an undifferentiated state or merely a result of rapid proliferation.  
Additionally, stem cells vary in their proliferation rates in vivo, as some stem cells are quiescent within 
their niche while others are proliferating34. We studied multiple tissue niches representing varying 
proliferation rates and observed that low dose IR-induced apoptosis was exclusive to stem cells 
independent of their proliferation status. The highly proliferative non-stem progenitors of the intestinal 
crypt underwent low levels of IR-induced apoptosis at higher doses, at which dose terminally 
differentiated non-dividing cells stay highly radioresistant. This demonstrates the stark contrast in 
radiation responses of cells at varying differentiation states in vivo, in which proliferation state appears 
only to affect the radiosensitivity of differentiated cells while stem cells are ubiquitously radiosensitive. 
Our findings provide compelling evidence against this established assumption about the true factors 
affecting cellular radiosensitivity and should lead to improved understanding of the true basis of stem cell 
hypersensitivity. 
According to the surviving fraction of cells irradiated in each phase following synchronization, G2/M is 
typically considered the most radiosensitive phase of the cell cycle followed by G1 and then S phase39, 
although large variability exists between cell lines38. In order to focus on the cell cycle responses to 
radiation that contribute to differential IR-induced apoptosis among ES and ED cells, we chose to assess 
cell cycle phase radiosensitivity through a unique approach.  We investigated whether differences in the 
cell cycle arrest of ES and ED cells were associated with a bias in the induction of apoptosis across 
different cell cycle phases post-irradiation.  By measuring the prevalence of FLICA -positive apoptotic cells 
across the cell cycle relative to the total cell cycle distribution, we were able to determine whether there 
exists any cell cycle phase bias among the apoptotic population in ES and ED cells.  We found that ES 
cells maintained apoptotic sensitivity fairly evenly throughout the cell cycle, which could explain stem cells 
radiation hypersensitivity, while apoptosis in ED cells was clearly higher towards G2. The hypersensitivity 
of stem cells to radiation may be aided by the fact that they remain relatively radiosensitive at all phases 
of the cell cycle, while radioresistant differentiated cells in contrast are only radiosensitive during a portion 
of the cell cycle. It is known that stem cells fail to activate G1 checkpoint arrest following DNA damage40–
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42 cells, suggesting a potential connection between the absence of a G1 checkpoint and a more broad 
distribution of apoptosis throughout the cell cycle.  
This work demonstrates stem cells are hypersensitive to IR both in culture and within multiple tissue 
niches.  We have shown that at therapeutic doses typically used in radiation therapy (2-10Gy)43, only 
stem cells undergo IR-induced cell death.  The clinical side effects from radiation therapy are therefore 
not due to loss of the stem cell compartment as a whole, but instead to the individual stem cells within the 
niche. By targeting radioprotective therapies and drugs toward radiosensitive stem cells substantial 
progress can be made towards minimizing damaging sequelae of radiation therapy, therefore improving 
the efficiency and effectiveness of radiation therapy overall. 
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CHAPTER 3 
Stem Cells Exhibit an Attenuated  
DNA Damage Response 
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3.1 ABSTRACT 
We have previously demonstrated that stem cells are hypersensitive to ionizing radiation (IR) and readily 
undergo IR-induced apoptosis while differentiated progeny are quite radioresistant. Here we investigate 
whether a uniquely aberrant DNA Damage Response (DDR) in stem cells contributes to this IR 
hypersensitivity. Our study determines that stem cells fail to sufficiently activate and maintain DDR 
signaling. Despite normal sensing of DNA breaks, recruitment/ retention of repair factors at DNA break 
sites is attenuated in stem cells. This attenuated DDR results in diminished DNA repair efficacy and 
improper cell cycle checkpoint arrest. Interestingly, while these stem cells are unable to induce γH2AX 
foci, during apoptosis they induce pan-nuclear H2AX S139 phosphorylation through the activation of 
MST1 and JNK. By investigating this pathway for the first time in stem cells, we provide a potential 
mechanism for IR-induced apoptosis independent of DDR signaling. We thus establish that molecular 
radiation responses can vary greatly from canonical signaling in specialized cell types such as stem cells, 
suggesting that DDR signaling is less ubiquitious than currently believed. 
 
3.2 METHODS 
3.2.1 Stem Cell Culture and Differentiation: 
Normal embryonic stem (ES) cells were freshly isolated directly from the inner cell mass of 
blastocyst stage mouse embryos (E4.5), and later procured from the Washington University 
Embryonic Stem Cell Core Facility or ATCC as karyotypically normal early passage ES cells 
(EDJ22, RW4).  Cells were grown feeder-free on gelatin-coated plates and maintained in high 
glucose DMEM with HEPES (Invitrogen) containing 10% Fetal Bovine Serum (Invitrogen), 10% 
Newborn Calf Serum (Invitrogen), 0.2% beta-mercaptoethanol (Invitrogen), a nucleoside mix 
containing final concentrations of 80μg/ml adenosine, 85μg/ml guanosine, 73μg/ml cytidine, 
73μg/ml uridine and 24μg/ml thymidine (Sigma Aldrich) and 10ng/ml LIF (Invitrogen). ES cells 
were passaged with 0.05% trypsin containing 0.53mM EDTA (Invitrogen) and selective isolation 
of independent colonies from any differentiated cells present.  They were differentiated by culture 
in the absence of LIF for several days.  ES cells were tested bi-monthly for mycoplasma 
contamination. 
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Neural stem cells were freshly isolated by dissecting the hippocampal region of brains from P0-
P2 mouse pups and were cultured in suspension after dissociation and trituration in AB2 Basal 
Neural Medium (Aruna Biomedical) containing 20ng/ml EGF, 10ng/ml bFGF, 1% N2-Supplement 
and 2% B27 (Invitrogen).  Neural stem cells were differentiated by addition of 10% FBS (Hyclone) 
and removal of EGF/FGF from culture medium upon plating into tissue culture-treated dishes for 
attachment.   
 
3.2.2 Animal Models: 
Wild-type mouse strain C57BL/6 was used for all in vivo assays unless otherwise noted.  Adult 6-
8 week old males were utilized for harvest of brain, intestine, skin and testis for sectioning.  For 
breeding, 1-6 month old male and female mice of similar age were allowed to mate continuously, 
with pregnant females isolated independently before giving birth.  P0-P2 mouse pups were 
sacrificed by rapid decapitation prior to dissection for neural stem cell isolation.  Procedures for all 
studies were been approved by the Animal Studies Committee at Washington University Medical 
Center. 
 
3.2.3 Antibodies 
Details of the antibodies used in this work are described in Table 3.1. 
 
 
Table 3.1. Antibody Information Table 
   Protein Target Species Company Catalog # Assay Conditions 
BrdU (AlexaFluor 488 
conjugated) mouse Invitrogen B35139 FACS 1:20 
Histone H2AX rabbit Cell Signaling #7631 IF, WB 
1:150, 1:2000 
in BSA 
Ku80 rabbit Cell Signaling #2753 IF 1:200 
MDC1 mouse Millipore 05-1572 IF 1:150 
MST1 rabbit Cell Signaling #3682 IHC-F 1:50 
NBS1 rabbit Abcam ab32074 IF 1:200 
Oct4 rabbit Abcam ab19857 IF, IHC-F 1:200, 1:200 
PCNA mouse Millipore NA-03 IHC-F 1:100 
phospho-ATM (S1981) mouse Rockland 200-301-400 IF 1:200 
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phospho-ATM (S1981) mouse Cell Signaling #4526 WB, IHC-F 
1:500 in milk, 
1:50 
phospho-ATR (S1989) rabbit GeneTex GTX128145 WB 1:1000 in BSA 
phospho-Chk1 (S345) rabbit Cell Signaling #2348 WB 1:1000 in BSA 
phospho-DNA-PK (S2056) rabbit Abcam ab18192 IF, IHC-F 1:200, 1:100 
phospho-H3 (S10) mouse Pierce MA5-15220 FACS 1:100 
phospho-JNK (T183/Y185) mouse Santa Cruz sc-6254 IHC-F, WB 1:50, 1:500 
phospho-MST1 (T183) rabbit Cell Signaling #3681 WB 1:1000 in BSA 
PLZF mouse Santa Cruz sc-28319 IHC-F 1:50 
Rad51 rabbit Santa Cruz sc-8349 IHC-F 1:100 
Sox2 rabbit Abcam ab7959 IHC-F 1:100 
Sox2 mouse Abcam ab79351 IF, IHC-F 1:200, 1:100 
SSEA1 mouse Abcam ab16285 IHC-F 1:100 
Total ATM rabbit Cell Signaling #2873 WB 1:1000 in BSA 
Total ATR rabbit Cell Signaling #2790 WB 1:500 in milk 
Total Chk1 mouse Cell Signaling #2360 WB 1: 1000 in milk 
γH2AX (S139) mouse Millipore 05-636 WB, IHC-F 
1:4000 in 
BSA, 1:400 
γH2AX (S139) rabbit Cell Signaling #7631 IHC-F 1:150 
GAPDH mouse Sigma Aldrich G8795 WB 
1:100,000 in 
milk 
FITC-conjugated anti-
rabbit donkey Vector FI-1000 IF, IHC-F 1:100 
FITC-conjugated anti-
mouse horse Vector FI-2000 IF, IHC-F 1:100 
AMCA-conjugated anti-
mouse horse Vector CI-2000 IF 1:75 
AMCA-conjugated anti-
rabbit donkey Vector CI-1000 IF 1:75 
Texas Red-conjugated 
anti-mouse horse Vector TI-2000 IF, IHC-F 1:100 
Texas Red-conjugated 
anti-rabbit donkey Vector TI-1000 IF, IHC-F 1:100 
HRP-conjugated anti-
mouse rabbit Sigma Aldrich A9044 WB 1:5000 in milk 
HRP-conjugated anti-
rabbit goat Sigma Aldrich A0545 WB 1:5000 in milk 
 
 
3.2.4 X-Ray Irradiation and Tissue Sectioning: 
Cells and animals were irradiated in the RS-2000 Biological Research Irradiator (Rad-Source) at 
room temperature, with mock/control irradiated samples brought into the room to simulate the 
reduction in ambient temperature and account for any stress imparted by the travel.  Cells were 
always placed within the central circle directly under the x-ray source to maintain consistency in 
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dose between samples.  Animals were anesthetized with isofluorane and placed on their back in 
the machine for whole-body irradiation to properly expose all tissues of interest to the x-ray 
source.  Accuracy of all doses was confirmed by dosimeter probe.  Both cells and animals were 
randomly assigned to individual timepoints or sham-irradiation controls.  
 
Following irradiation, mice were sacrificed at specific timepoints by CO2 asphyxiation and cervical 
dislocation.  Organs were harvested, placed in OCT media and frozen in liquid nitrogen.  Frozen 
tissues were sectioned on a cryostat machine at a thickness of 10μm, placed onto adhesive 
slides and stored at -80oC.  
 
3.2.5 Western Blotting: 
Cellular protein lysates were collected in RIPA buffer, electrophoresed on 4-15% Tris-Glycine 
polyacrylamide gels (BioRad), transferred onto PVDF membranes and incubated overnight at 4oC 
with various primary antibodies followed by washing and secondary antibody incubation for 2hr at 
room temperature. Super ECL (GE/Pierce) was used as substrate for detection on 
autoradiography film or ChemiDoc MP digital system (BioRad).  
 
3.2.6 Immunofluorescence: 
Freshly frozen tissues were isolated from testis, brain, intestine and skin following 6Gy irradiation 
or 0Gy mock before embedding in OCT media and sectioning onto slides.  Slides of tissue 
sections or coverslips of cells were fixed in 4% formaldehyde and permeabolized with 0.2% 
Triton-X followed by blocking with 2% BSA. Tissues were incubated with primary antibodies in 1% 
BSA at 37oC for 3hr, washed and then incubated with secondary fluorescently-tagged secondary 
antibodies for 45min at 37oC.  Tissues were then mounted in place with coverslips containing 
mounting media with DAPI (Vector) for identification of nuclei.   
  
Cells were similarly fixed in 4% formaldehyde and permeabilized with 0.2% Triton-X before 
blocking.  For double-color staining, primary antibodies were incubated together for 1hr at 37oC 
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followed by wash and incubation with fluorescently-tagged secondary antibodies for 30min at 
37oC.  For triple-color staining, following the original staining procedure, cells were incubated with 
1:1000 α-γH2AX antibody for 15min at 37oC followed by 12min incubation at 37oC with the 
appropriate secondary antibody.  Anti γH2AX antibody was chosen to match Sox2 to avoid cross-
reaction with the other target antigen of interest.  
 
3.2.7 Neutral Comet Assay: 
To assess repair of DNA double strand breaks, neutral comet assays were performed using 
CometSlide assay kits (Trevigen). Cells were collected at multiple timepoints following 6 Gy 
irradiation or 0 Gy mock and embedded in agarose on slides at equal concentrations. Slides were 
electrophoresed in TAE buffer, fluorescently stained with SYBR Green (Trevigen), and visualized 
by fluorescent microscopy. Olive comet moment was calculated using the CometScore software 
(TriTek) to analyze 50-100 comets per sample, with each series of timepoints repeated at least 
three independent times as both biological and technical replicates.  Individual comets were 
randomly selected for scoring from similar regions of the slide in all samples. Outliers were 
eliminated that fell greater than 1.5 standard deviations from the mean. Standard error was 
calculated for each cell type and timepoint normalized to the value of the 0min samples, while the 
significance of the difference between cell types over time was analyzed by Analysis of 
Covariance (ANCOVA) using XLStat statistical software (Addinsoft), with two-sided significance 
set at p<0.05.  Data from all samples was approximately normally distributed, and the standard 
deviation between samples within the same experiment was similar.  Samples were excluded 
from analysis only due to technical errors from the assay or cells being visibly unhealthy.   
 
3.2.8 Laser Microirradiation 
Stem cells (ES, NS) were co-plated with non-stem cells (ED, MEF) on glass coverslips and 
incubated for 2 days with 30μM BrdU (Sigma Aldrich) to sensitize DNA for DSB induction.  Prior 
to laser microirradiation, cells were incubated with Stem Cell cDy1 Dye (Active Motif) for 30min to 
fluorescently label live stem cells for identification.  Coverslips were then placed in circular 
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magnetic chambers (Quorum Technologies) with media to be properly aligned for 
microirradiation.  Cells were microirradiated in a defined narrow region across adjacent stem and 
non-stem cells with 8000-12000 iterations of 405+633nm laser on the LSM 510 Confocal 
Microscope (Zeiss) at 45% power output. Care was taken to include stem (cDy1 positive) as well 
as non-stem cells in the DNA damage tracks. Cells were microirradiated for 20-30min per sample 
unless otherwise stated, with 6-12 regions of microirradiation per sample.   
 
3.2.9 Cell Cycle Analysis 
For cell cycle profiling, cells were isolated at various timepoints following irradiation and ethanol-
fixed overnight at -20oC. Ethanol-fixed cells were washed and incubated with RNase for 30min at 
37oC for 30min before staining with propidium iodide and analyzing by flow cytometry. 
 
ES and ED cells were incubated with 20μM BrdU (Sigma) for 30min, irradiated, washed 2 times 
and chased for various timepoints to allow cell cycle progression. Cells were then fixed overnight 
in ethanol at -20oC, incubated with RNase and propidium iodide, and analyzed by flow cytometry.   
 
For G2/M checkpoint arrest, cells were first ethanol-fixed at various timepoints following sham or 
6Gy irradiation.  Cells were then washed, blocked in 2% BSA and incubated for 1h with phospho-
histone H3 (S10) antibody at 37oC to label mitotic cells. Following washes, cells were incubated 
with 1:100 FITC-conjugated anti-mouse 2o antibody for 30min at room temperature. Following 
another wash cells were incubated with RNase and propidium iodide as before and analyzed by 
flow cytometry. G2/M arrest was indicated by decrease in the percentage of mitotic cells. 
 
3.2.10 Cytogenetic Analysis 
Cells were incubated with 100ng/ml colcemid for 2-4hrs following 6Gy irradiation or 0Gy mock to 
arrest cells in metaphase. Mitotic cells were selectively isolated by mitotic shake-off, incubated in 
hypotonic buffer (0.56% KCl) for 8 min, fixed in acetate-methanol and dropped onto slides. 
Fluorescent in situ hybridization was performed using oligonucleotide (TTAGGG)3 PNA probes 
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using standard protocols and counterstained with DAPI.  Chromosomes were then visualized by 
fluorescence microscopy and scored for chromosome aberrations. The number of chromosome 
aberrations was normally distributed for each sample, with similar standard deviations between 
samples from the same time point. Each sample was repeated three times. Chromosome 
aberrations were defined as chromosome or chromatid breaks, translocations, or radials. 
Standard error was calculated and statistical significance was determined by Student’s t-test, with 
two-sided significance set at p<0.05. Only full chromosome plates were scored, any partial plates 
were excluded from scoring. 
 
3.2.11 Microscopy and Image Processing 
Micrographs were captured utilizing MetaSystems ISIS imaging software on Zeiss Axioplan2 
microscope or ZEN software on Zeiss LSM510 confocal microscope with the 20x, 63x or 100x 
objective lenses. Minimal threshold and contrast manipulation was performed equally across 
entire images. Controls were processed equally with treated samples. Adobe Photoshop CS3 
software was utilized for composing the collages of multiple pictures and labeling micrographs 
and Immunoblots in individual layers.  
 
3.2.12 Statistical Analysis 
A ‘two-tailed’ Student's t-test was used to calculate the statistical significance of the observed 
differences. In all cases, differences were considered statistically significant when  p<0.05. 
Unless otherwise indicated, values represent mean ± SEM. 
 
3.3 INTRODUCTION 
Radiation therapy utilizes ionizing radiation (IR) to produce lethal DNA double-strand breaks (DSBs) in 
cancer cells; however detrimental sequelae often result from unintended damage to normal tissue. Work 
from previous chapters elucidated that these consequences are likely due to the loss of stem cells from 
the affected tissue niche, as IR induces apoptosis only in stem cells while differentiated cells are 
radioresistant. Having established that stem cells are hypersensitive to IR both in vivo and in culture, we 
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examined the molecular mechanisms responsible for this differential radiosensitivity among stem and 
differentiated cells. An improved understanding of cellular radiation responses is essential for the 
development of strategies to protect normal tissue during radiotherapy. 
 
Aberrant DNA damage response (DDR) signaling often leads to genomic instability and cell death 1, 
suggesting that inadequate DDR signaling and DNA repair may contribute to radiation hypersensitivity. 
The DDR is an intricate network of molecular signaling following DSBs that enables proper damage 
sensing, recruitment of repair factors and subsequently DNA repair. In mammals, the Mre11–Rad50–
Nbs1 (MRN) complex initially senses  DNA breaks 2,3. This is followed by activation of phosphatidylinositol 
3-kinase-related kinases (PIKKs), which include ataxia telangiectasia mutated (ATM), ATM and Rad3-
related (ATR), and DNA-dependent protein kinase catalytic subunit (DNA-PKcs). Activated ATM 
phosphorylates histone H2AX on serine 139, marking mega-bases of chromatin around the DSB with 
γH2AX 4,5, and serving as a docking site for downstream repair factors 6. Following repair factor assembly 
and cell cycle checkpoint activation, the DDR initiates DNA DSB repair. In the absence of efficient repair, 
apoptosis may be induced to eliminate cells with compromised genomic integrity 1. 
 
Here we establish that stem cells across multiple tissue niches and culture models exhibit a severely 
attenuated DDR, demonstrating reduced activation and recruitment of various DDR and DNA repair 
factors following irradiation. We also show that stem cells demonstrate limited DNA repair and insufficient 
cell cycle checkpoint arrest, resulting in DDR-independent apoptosis through the MST1-JNK-H2AX 
pathway. By elucidating that stem cell radiosensitivity is associated with an abrogated DDR and 
inadequate DNA repair capacity, this work identifies potential molecular targets for radioprotecting stem 
cells to improve patient outcomes following radiation therapy. 
 
 
3.4 RESULTS 
3.4.1Stem cells exhibit an attenuated DDR 
 We utilized tissue sections isolated from brain, testis, intestine and skin in order to delineate 
 whether any differences in the DDR among stem and non-stem cells in vivo was associated with 
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 their previously observed differential radiosensitivity.  We observed a remarkable absence of 
 γH2AX foci from individually labeled stem cells in all tissues surveyed shortly following irradiation, 
 while adjacent non-stem cells displayed robust IR-induced foci (IRIF) formation (Fig. 3.1) 
 compared to unirradiated controls (Fig 3.2). We then utilized subnuclear laser microirradiation in 
 order to observe recruitment of DDR factors to defined regions of DNA damage in culture. Stem 
 cells in culture also exhibited strongly attenuated IR-induction of γH2AX both along 
 microirradiation-induced DSBs (Fig. 3.3 A-B) and globally (Fig. 3.4 A) compared to equivalently-
 treated non-stem cells. Total H2AX levels were similar among the cell types and remained 
 unchanged following irradiation (Fig. 3.4 A-B). H2AX S139 is phosphorylated primarily by 
 activated ATM kinase4,5. We therefore investigated whether repressed ATM activation is 
 responsible for the abrogation of γH2AX formation in stem cells. Immunoblots showed markedly 
 reduced activation of ATM by phosphorylation of serine 1981 (pATM) in stem cells without any 
 reduction in total ATM levels (Fig. 3.5). ATM activation can also occur independently of its 
 recruitment to DNA damage7, hence we assessed the recruitment of pATM to DSBs. Subnuclear 
 microirradiation confirmed the inability of stem cells to adequately activate and recruit pATM to 
 DNA breaks, while in contrast co-plated and co-treated non-stem cells displayed robust 
 recruitment of pATM to the damaged region (Fig. 3.6). Complete abrogation of ATM activation 
 and recruitment was also observed in vivo following irradiation (Fig. 3.7 A-B). Immunoblotting of 
 stem cells in culture also demonstrated reduced ATR activation as indicated by both decreased 
 phosphorylation of the DNA damage-responsive serine 1989 site8 and diminished activation of 
 the ATR substrate checkpoint kinase 1 (Chk1) (Fig. 3.8).  
 
Stem cells failed to recruit activated non-homologous end joining  (NHEJ) repair factor DNA-PKcs 
(pDNA-PKcs) phosphorylated at serine 2056 9 both in culture (Fig. 3.9 A) and in vivo within the 
SGZ (Fig. 3.9 B). Rad51 foci indicating homologous recombination (HR) repair were also not 
detected in stem cells in vivo within irradiated testis and intestine (Fig. 3.10 A-B). Despite the 
presence of actively proliferating stem cells in vivo (Fig. 2.11), only proliferating differentiated 
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cells displayed Rad51 foci. Together these data clearly demonstrate that stem cells exhibit 
severely abrogated induction and recruitment of DDR factors in response to IR. 
 
 
 
 
 
 
 
Figure 3.1. Absence of γH2AX IRIF in stem cells in vivo.  Immunofluorescence co-staining of stem cell 
markers (red; Sox2, SSEA1, Oct4) and γH2AX (green) in tissue niches 15min following 6Gy IR. 
DAPI=DNA.  Arrows indicate stem cells in vivo lacking γH2AX IRIF. 
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Figure 3.2. Sham-irradiated negative controls for in vivo γH2AX IRIF. Immunofluorescence co-
staining of stem cell markers (red, Sox2, Oct4) and γH2AX (green) in tissue niches following sham 
irradiation. 
Figure 3.3. γH2AX induction is attenuated along DSBs in cultured stem cells. Immunofluorescence 
co-staining of (A) Sox2 (green) and γH2AX (red) on co-plated ES and ED cells, DAPI=DNA, or (B) Sox2 
(blue) and γH2AX (red) on co-plated NS and ND cells 30min following microirradiation. DAPI=DNA. 
γH2AX was substantially attenuated in approximately 70% of laser tracks. White scale bars, 10µm. 
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Figure 3.4. Global attenuation of IR-induced γH2AX in cultured stem cells is not due to reduced 
H2AX expression. (A) Western blots for γH2AX and histone H2AX at various time points following 
mock or 6Gy irradiation of ES and ED cells. GAPDH served as a loading control. (B) 
Immunofluorescence co-staining of Sox2 (blue) and histone H2AX (red) on co-plated unirradiated ES 
and ED cells. White scale bars, 10μm. 
Figure 3.5. IR-induced ATM activation is attenuated in cultured stem cells. Western blots for 
pATM and total ATM at various time points following mock or 6Gy irradiation of ES and ED cells. 
GAPDH served as a loading control. 
 77 
 
 
Figure 3.6. pATM is not recruited to DSBs in cultured stem cells. Immunofluorescence co-
staining of Sox2 (blue) and pATM (green) on co-plated ES and ED cells following 
microirradiation. White scale bars, 10µm. 
Figure 3.7. IR-induced activation and recruitment of ATM IRIF is attenuated in stem cells in vivo. 
Immunofluorescence co-staining of Sox2 (red) and pATM (green) in brain 15min following (A) sham or (B) 
6Gy IR. DAPI=DNA. White scale bars, 10µm. 
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Figure 3.8. IR-induced ATR activation is attenuated in cultured stem cells. Western blots for 
pATR, total ATR, pChk1 and total Chk1 on ES and ED cells at various time points following mock or 
6Gy irradiation of ES and ED cells. GAPDH served as a loading control. 
Figure 3.9. Recruitment of pDNA-PKcs to DSBs is attenuated in stem cells both in culture 
and in vivo. (A) Immunofluorescence co-staining of Sox2 (blue), γH2AX (red) and pDNA-PKcs 
(green) on co-plated ES and ED cells following microirradiation. (B)  Immunofluorescence co-
staining of Sox2 (red) and pDNA-PK (green) in brain 4h following sham or 6Gy IR. DAPI=DNA.  
White scale bars, 10μm. 
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3.4.2 Stem cells display impaired cell cycle arrest compared to differentiated cells 
To examine whether a difference in cell cycle control could be connected to the increased 
apoptosis in stem cells, the cell cycle distributions of ES and ED were analyzed after IR. 
Beginning at 2 h and maximizing at 6-8 h, IR induced the accumulation of cells in G2 in both ES 
and ED cells (Fig. 3.11). In agreement with our previous experiments, only ES cells displayed a 
strong induction of a subG1 population representing the apoptotic fragmentation of DNA. 
Additionally, in ES cells IR induced a greater shift in the ratio towards G2, while they show almost 
a complete absence of G1 accumulation. In contrast, ED cells maintained a substantial G1 
population at all time points. Moreover, pulse-chase of BrdU-labeled ES and ED cells up to 8h 
after irradiation confirmed the lack of G1 accumulation in stem cells (Fig. 3.12). These results 
suggest an absence of G1 arrest in ES cells, unlike their isogenic differentiated cells. G2/M 
checkpoint arrest has previously been observed in ES cells10,11, however the details of G2/M 
arrest has not been compared between stem and differentiated cells. In order to assess both the 
initiation and maintenance of G2/M arrest, we quantified the percentage of cells staining positive 
Figure 3.10. Rad51 recruitment to IRIF is attenuated in stem cells in vivo. Immunofluorescence co-
staining of (A) PLZF (red) and Rad51 (green) in testis and (B) Rad51 (green) alone in intestine 4h 
following sham or 6Gy IR. DAPI=DNA. White scale bars, 10µm. 
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for the mitosis marker histone H3 serine 10 phosphorylation at multiple timepoints following 
irradiation. Our results showed that both stem and non-stem cells demonstrate a rapid G2/M 
arrest as indicated by the decrease in mitotic cells within 1h of irradiation. Contrary to 
differentiated cells however, ES cells were unable to fully block mitotic entry and were completely 
released from G2/M arrest by 9h post-irradiation (Fig. 3.13). ED cells are able to completely block 
cell cycle progression into mitosis and in contrast show sustained maintenance of G2/M arrest up 
to 12h following irradiation. Weaker cell cycle checkpoint controls in stem cells may serve as an 
additional contributing mechanism toward their enhanced radiosensitivity.  
 
 
 
Figure 3.11. Cell cycle profile overlays of irradiated stem and non-stem cells. Cell cycle 
profiles of ES and ED cells were collected at multiple timepoints following sham or 4Gy IR. Blue 
outline, ES; red outline, ED. 10,000 gated cells were counted for analysis. 
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Figure 3.12. BrdU pulse-chase profiles of irradiated stem and non-stem cells. ES and ED 
cells were labeled with BrdU and chased for multiple timepoints following sham or 4Gy IR. 
Rectangles indicate the presence of G1, S, and G2 populations. Solid rectangle, G1 population; 
dotted rectangle, absence of G1 population. 20,000 gated cells were counted for analysis. 
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3.4.3 Stem cells fail to adequately repair DSBs  
Differences in DNA repair proficiencies between stem and non-stem cells in culture were then 
quantified. The non-stem cells exhibited efficient repair as indicated by rapid reduction of DNA 
breaks within 1h of irradiation (Fig. 3.14). Stem cells in contrast exhibited significantly diminished 
repair efficiency, paralleling the repair kinetics of H2AX -/- cells 12. Stem cells ultimately failed to 
show substantial DNA repair until 4h post-IR, when many of the radiosensitive cells had already 
begun dying and dropping out of the population (Fig. 2.9). Stem cells also displayed significantly 
higher incidences of unrepaired chromosome/chromatid breaks and fragmented/blebbing nuclei 
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Figure 3.13. Stem cells exhibit a shortened G2 checkpoint arrest. ES and ED cells were collected at 
multiple timepoints following sham or 6Gy irradiation and mitotic cells were labeled with phospho-histone 
H3 (S10).  G2/M arrest was measured by observed reduction in the percentage of mitotic cells in the 
population. 
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following IR, while only minimal aberrations were seen in unirradiated controls (Fig. 3.15 A-B, 
3.16). Despite attenuated DDR signaling, we did observe recruitment of the MRN complex protein 
Nibrin (NBS1) to microirradiation tracks in stem cells (Fig. 3.17) along with Ku80 (Fig. 3.18), 
another early responder to DSBs as part of the Ku70/80 heterodimer 13. The presence of these 
factors may enable the observed low level of basal repair (Fig. 3.14). Inhibition of the DDR in 
stem cells thus leads to reduced DNA repair efficiency and likely relates to their reduced 
threshold for DNA damage-induced apoptosis. 
 
 
 
Figure 3.14. Neutral comet assay on stem and non-stem cells to measure DNA repair. Olive 
moments of NS and ND cell comet assay tails were quantified at different timepoints following 
sham or 6Gy IR and normalized to the irradiated 0min timepoint in order to measure DNA repair 
over time. The difference in olive moment across the entire timecourse was significant by 
ANCOVA, p = 0.013; N=3. Error bars indicate SEM. 
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Figure 3.15. Chromosome preparations from stem and non-stem cells. (A) Metaphase chromosomes 
isolated from unirradiated ES, ED, NS and ND cells. (B) Metaphase chromosomes and fragmented nuclei 
isolated from ES, ED, NS and ND cells following 6Gy IR. Red, telomere; DAPI=DNA. Arrowheads indicate 
clusters of chromosome aberrations. 
Figure 3.16. Cultured stem cells show more residual chromosomal aberrations than non-stem 
cells following irradiation. Chromosome aberrations were quantified in stem and non-stem cells 
following 2Gy or sham irradiation. N=3; **, p < 0.01. Aberrations were scored as the sum of 
chromosome/chromatid breaks, translocations, and radials. Error bars indicate SEM. 
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Figure 3.17. MRN complex is recruited to 
DSBs in cultured stem cells. 
Immunofluorescence co-staining of Sox2 
(blue), γH2AX (red) and NBS1 (green) on 
co-plated ES and ED cells following 
microirradiation. Arrowhead indicates the 
presence of NBS1 despite attenuated 
induction of γH2AX. White scale bar, 10µm. 
Figure 3.18. Ku complex is recruited to 
DSBs in cultured stem cells. 
Immunofluorescence co-staining of Sox2 
(blue), γH2AX (red) and Ku80 (green) on co-
plated ES and ED cells following 
microirradiation. Arrowhead indicates the 
presence of Ku80 despite attenuated 
induction of γH2AX. Individual ES and ED 
pictures shown were irradiated together 
following co-plating. White scale bar, 10µm. 
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3.4.4 IR-induced apoptosis in stem cells involves MST1-JNK-H2AX pathway 
While IR-induced apoptosis typically involves DDR signaling through ATM and p53 14, stem cells  
underwent IR-induced apoptosis despite deficiencies in DDR signaling and DNA damage-induced 
apoptosis in stem cells has been shown to be p53-independent 15.  The ability of stem cells to 
apoptose despite the absence of DDR components was confirmed by observing apoptosis in the 
stem cell regions of DDR factor-deficient mice (Fig. 3.19). We therefore investigated potential 
alternative apoptotic pathways that could be active in stem cells. Once activated by caspase 
cleavage 16, autophosphorylation 17 and subsequent nuclear translocation, mammalian Ste20-like 
kinase (MST1) pan-phosphorylates H2AX-S139 in addition to activating c-Jun N-terminal kinase 
(JNK)18, which can in turn also pan-phosphorylate H2AX-S139 19.  Despite the absence of γH2AX 
IRIF in stem cells (Fig. 3.1, 3.3), by 6h post-irradiation they induced pan-nuclear H2AX S139 
phosphorylation (H2AX-pS139) (Fig. 3.20 A-B). MST1 was phosphorylated only in stem cells 
following irradiation (Fig. 3.21), and pan-nuclear H2AX-pS139 signals colocalized with nuclear 
translocation of otherwise cytoplasmic MST1 in the SGZ at late timepoints (Fig. 3.22). 
Additionally, JNK was found to be activated through its phosphorylation (pJNK) only in stem cells 
at these late timepoints following irradiation both in culture (Fig. 3.21) and in vivo (Fig. 3.23 A-B). 
pJNK also co-stained with pan-nuclear H2AX-pS139 (Fig. 3.24) in the SGZ stem cell region. IR-
induced apoptosis in stem cells therefore does not require DDR components and signals through 
the MST-JNK-H2AX pathway. 
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Figure 3.19. Apoptosis in stem cell regions in vivo does not require DDR components. 
Immunofluorescence staining of cleaved poly (ADP-ribose) polymerase (PARP) in H2AX -/-, SCID, 
and ATM -/- brain 6h following 6Gy IR. DAPI=DNA. White scale bars, 10µm. 
Figure 3.20. Stem cells in vivo induce pan-nuclear H2AX-pS139 at late timepoints following 
irradiation. (A) Immunofluorescence co-staining of Sox2 (red) and pan-nuclear H2AX-pS139 (green) in 
brain 6h following 6Gy IR. (B) Immunofluorescence staining of pan-nuclear H2AX-pS139 (green) in 
tissue niches 6h following 6Gy IR. Arrows indicate apoptotic H2AX-pS139 in stem cell regions. 
DAPI=DNA.  White scale bars, 10µm. 
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Figure 3.21. MST1 and JNK are activated only in cultured stem cells at late timepoints 
following irradiation. Western blots for pMST1 at various time points following mock or 
6Gy irradiation of NS and ND cells along with western blots for pJNK at various time points 
following mock or 6Gy irradiation of ES and ED cells. GAPDH served as a loading control. 
Figure 3.22. MST1 is nuclear translocated correlating with the onset of H2AX-pS139 in 
stem cell regions. Immunofluorescence co-staining of MST1 (red) and pan-nuclear H2AX-
pS139 (green) in brain 15min, 1h and 6h following 6Gy IR. DAPI=DNA. White scale bars, 10μm. 
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Figure 3.23. pJNK is activated in stem cells in vivo at late timepoints following irradiation. 
Immunofluorescence co-staining of (A) pJNK (green) and Sox2 (red) in brain  and (B) pJNK (green) and Oct4 
(red) in testis 6h following either sham or 6Gy IR. DAPI=DNA. White scale bars, 10μm. 
Figure 3.24. pJNK colocalizes with H2AX-pS139 in stem cell regions. Immunofluorescence co-
staining of pJNK (red) and pan-nuclear H2AX-pS139 (green) in brain 6h following 6Gy IR. DAPI=DNA. 
White scale bar, 10μm. 
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3.5 DISCUSSION 
This work demonstrates that normal stem cells in vivo as well as in culture exhibit an aberrant DDR and 
are deficient in repairing DNA DSBs compared with their isogenic differentiated non-stem progeny. Our 
most striking finding is the austere lack of IRIFs in stem cells, including pATM and γH2AX. Stem cells 
therefore appear to be unique in their inability to activate the DDR, demonstrating stark heterogeneity in 
the molecular responses to DNA damage among cells of varying differentiation status. This suggests that 
not all cells respond similarly to DNA damage, challenging existing assumptions about the ubiquitous 
nature of the DDR and its generalizability to all cell types. 
 
While stem cells are unable to induce IRIFs, they are able to sense DNA breaks through the recruitment 
of Nbs1 and Ku80, in agreement with previous studies demonstrating that MRN recruitment does not 
require H2AX or its phosphorylation20–22. The MRN complex is sufficient for promoting DNA repair 
independent of H2AX22,23, which may explain how stem cells are able to repair endogenous physiological 
levels of damage despite an attenuated DDR. The kinetics of DSB repair in stem cells are similar to H2AX 
-/- murine embryonic fibroblasts12, further indicating that stem cells are essentially a naturally-occurring 
DDR-null cell type. This similarity also causally links their attenuated DDR and muted DNA repair. 
Additionally, the radiosensitivity of ATM and H2AX-deficient cells has been attributed to their DSB repair 
defects 24,25, suggesting that the inhibited DDR signaling and DSB repair capacity of stem cells may 
directly influence their radiosensitivity. 
 
There are conflicting reports on the relative efficiency of cultured stem cells in repairing DNA damage26–31, 
and DDR activation in stem cells has also been observed by several groups11,32–34. However, many of 
these studies did not emphasize the use of early passage, primary cultures or isogenic direct 
differentiation as our study does, and prolonged passage of stem cells in culture results in epigenomic 
changes35 that lead to modified radiation responses [unpublished observations]. Additionally, mouse and 
human ES cells appear to differ in their radiation responses36. In agreement with our studies, murine ES 
cells (albeit not human ES cells) have been reported as deficient in repairing DNA breaks36 and murine 
induced pluripotent stem cells have recently been found to exhibit inadequate H2AX phosphorylation and 
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DNA repair37. Unirradiated ES cell lines have been found to exhibit high basal γH2AX levels that are 
believed to be important for self-renewal38, but this basal γH2AX appears to be independent of DDR 
signaling39. These discrepancies also reinforce the significance of corroborating work with in vivo tissue 
niches when possible, as was done in our study.   
 
Studies on intestinal crypts40,41 have observed the presence of IRIFs in stem cells but also demonstrated 
IR-induced cell death in those same cells. Stem cells within the hair follicle have been shown to 
sufficiently activate the DDR42, however it appears that the hair follicle may contain distinct stem cell 
populations43 with varying biological radiation responses. Our observations in testicular stem cells agree 
with previous studies showing abrogated γH2AX induction following IR44 (however again with 
contradictory radiosensitivity data).Variability among this data is likely due to the presence of different 
stem cell populations within these niches as well as developmental heterogeneity related to the continual 
turnover of each tissue compartment.  All of our work on brain stem cells is novel, as radiation responses 
in brain have only been previously studied in a developmental context without the use of specific stem cell 
markers45,46.   
 
While ED cells appear to arrest at both G1 and G2 checkpoints after irradiation, ES cells accumulate in 
G2, suggesting a lack of G1 checkpoint activation and subsequent arrest. This result agrees with existing 
reports suggesting that stem cells lack a functional G1 checkpoint11,15,47, which is in part due to both a 
nonfunctional p21 pathway48 and improper Chk2 localization49. Restoration of the G1 checkpoint has 
been shown to significantly reduce IR-induced apoptosis50,51, supporting the idea that an absent G1 
checkpoint may contribute to stem cell hypersensitivity. The length of IR-induced G2 arrest among cells 
typically correlates with cell cycle time 52. ES cells do not have a substantially longer cell cycle than ED 
cells however, yet employ a unique cell cycle response to radiation. ES cells rapidly activated IR-induced 
G2/M arrest similar to ED cells, however ED cells showed a much more gradual release from arrest. This 
shortened length of G2/M arrest in stem cells is likely due to their reduced activation of ATR and Chk1 
10,53,54. We also cannot ignore the possibility that by later timepoints many radiosensitive stem cells may 
have already died, whereby the observed restoration of the basal mitotic ratio merely represents an 
 92 
 
artifact of the remaining survivor population. Interestingly, while the length of G2/M entry delay among  
different cell types following DNA damage-induced S-phase arrest may directly correlate with 
radiosensitivity55, the relationship between G2/M arrest and radiosensitivity is less clear56. Nonetheless, 
reduced length of G2/M arrest in stem cells may hamper proper completion of DNA repair and limited 
evidence does correlate reduced G2/M arrest with radiosensitivity, especially in cells already lacking G1 
arrest57,58.    
 
We observed apoptotic signaling through the JNK-MST1-H2AX pathway only in stem cells both in culture 
and in vivo. While MST1 activation was a downstream result of apoptosis signaling, evidence suggests 
that it may also directly promote apoptosis by blocking Bcl-xL59. MST1-mediated H2AX pan-
phosphorylation at S139 is required for completion of apoptosis through DNA fragmentation16,19. Our work 
suggests that stem cells do not require DDR signaling for apoptosis, in agreement with another report 
which found that ATM deficiency only prevented IR-induced apoptosis in differentiated neuronal cells 
while stem cells remained radiosensitive 60. The JNK-MST1-H2AX pathway may represent an alternative 
mechanism for IR-induced apoptosis in the absence of DDR signaling. The observation of apoptosis in 
H2AX -/- cells suggests that other pathways may also be active in stem cells, however H2AX-pS139 is 
only involved in the final “clean-up” stages of apoptosis 19 so upstream signaling would not be affected. It 
is interesting that apoptotic pan-nuclear phosphorylation of S139 occurs in stem cells, despite abrogated 
γH2AX (ATM-mediated S139 phosphorylation around DNA break sites) immediately following DNA 
damage. We submit that chromatin changes induced by the onset of apoptosis may allow access to the 
break site and thus enable pan-nuclear S139 phosphorylation. 
 
One may wonder how stem cells would have developed such a radiosensitive phenotype. While the 
decision by stem cells to undergo apoptosis in response to IR in lieu of repairing the DNA damage may 
be an adaptive response, wherein the long-term genomic integrity of the lineage is protected by removing 
damaged stem cells, these radiation responses may also be merely a coincidence of their distinctive 
chromatin environment and epigenetic profile. Regardless, these findings provide novel insights in the 
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fields of DDR and normal stem cell biology, while also identifying potential new molecular targets for 
preventing stem cell depletion associated with radiotherapy.  
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CHAPTER 4 
Unique Epigenetic Regulation Contributes to 
Stem Cell Radiosensitivity 
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4.1 ABSTRACT 
Our work has shown that stem cells are uniquely hypersensitive to IR, readily undergoing IR-induced 
apoptosis and failing to sufficiently activate DNA repair signaling pathways. Stem cells exhibit an 
attenuated DNA Damage Response (DDR), which leads to diminished DNA repair capacity and DDR-
independent apoptosis. Various histone modifications have been implicated as playing an important role 
in the molecular responses to DNA damage. Since stem cell pluripotency is controlled by several uniquely 
regulated histone modifications, we investigated whether the distinctive epigenetic environment of stem 
cells could contribute to their radiosensitivity and abrogated DDR. We found that IR-induced apoptosis in 
stem cells corresponds to the persistence of H2AX-Y142 phosphorylation around break sites, which 
promotes apoptosis through JNK while inhibiting DDR signaling. The abrogated DDR in stem cells is also 
associated with constitutively elevated histone-3 lysine-56 acetylation, which may hinder retention of 
repair factors and directly contributes to stem cell radiosensitivity. These data establish that unique 
epigenetic landscapes among differing cell types can impart heterogeneity in the DDR, resulting in 
varying radiosensitivities. 
 
4.2 METHODS 
4.2.1 Stem Cell Culture and Differentiation: 
Normal embryonic stem (ES) cells were freshly isolated directly from the inner cell mass of 
blastocyst stage mouse embryos (E4.5), and later procured from the Washington University 
Embryonic Stem Cell Core Facility or ATCC as karyotypically normal early passage ES cells 
(EDJ22, RW4).  Cells were grown feeder-free on gelatin-coated plates and maintained in high 
glucose DMEM with HEPES (Invitrogen) containing 10% Fetal Bovine Serum (Invitrogen), 10% 
Newborn Calf Serum (Invitrogen), 0.2% beta-mercaptoethanol (Invitrogen), a nucleoside mix 
containing final concentrations of 80μg/ml adenosine, 85μg/ml guanosine, 73μg/ml cytidine, 
73μg/ml uridine and 24μg/ml thymidine (Sigma Aldrich) and 10ng/ml LIF (Invitrogen). ES cells 
were passaged with 0.05% trypsin containing 0.53mM EDTA (Invitrogen) and selective isolation 
of independent colonies from any differentiated cells present.  They were differentiated by culture 
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in the absence of LIF for several days.  ES cells were tested bi-monthly for mycoplasma 
contamination. 
 
Neural stem cells were freshly isolated by dissecting the hippocampal region of brains from P0-
P2 mouse pups and were cultured in suspension after dissociation and trituration in AB2 Basal 
Neural Medium (Aruna Biomedical) containing 20ng/ml EGF, 10ng/ml bFGF, 1% N2-Supplement 
and 2% B27 (Invitrogen).  Neural stem cells were differentiated by addition of 10% FBS (Hyclone) 
and removal of EGF/FGF from culture medium upon plating into tissue culture-treated dishes for 
attachment.   
 
4.2.2 Animal Models: 
Mouse strain C57BL/6 was used for all animal studies.  Adult 6-8 week old males were utilized for 
harvest of brain, intestine, skin and testis for sectioning.  For breeding, 1-6 month old male and 
female mice of similar age were allowed to mate continuously, with pregnant females isolated 
independently before giving birth.  P0-P2 mouse pups were sacrificed by rapid decapitation prior 
to dissection for neural stem cell isolation.  Procedures for all studies were been approved by the 
Animal Studies Committee at Washington University Medical Center. 
 
4.2.3 Antibodies 
Details of the antibodies used in this work are described in Table 4.1. 
 
Table 4.1. Antibody Information Table 
   Protein Target Species Company Catalog # Assay Conditions 
Acetylated Histone 3 (K56) rabbit Millipore 04-1135 IF, IHC-F 1:250, 1:100 
Histone H2AX rabbit Cell Signaling #7631 IF, WB 
1:150, 1:2000 
in BSA 
Histone H3 rabbit Cell Signaling #4499 IF 1:250 
phospho-H2AX (Y142) rabbit Abcam ab9045 IF, WB 1:200, 1:2000 
Sox2 rabbit Abcam ab7959 IHC-F 1:100 
Sox2 mouse Abcam ab79351 IF, IHC-F 1:200, 1:100 
γH2AX (S139) mouse Millipore 05-636 WB, IHC-F 
1:4000 in 
BSA, 1:400 
γH2AX (S139) rabbit Cell Signaling #7631 IHC-F 1:150 
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p300 rabbit Santa Cruz 
 
WB 1:4000 in milk 
GAPDH mouse Sigma Aldrich G8795 WB 
1:100,000 in 
milk 
FITC-conjugated anti-
rabbit donkey Vector FI-1000 IF, IHC-F 1:100 
FITC-conjugated anti-
mouse horse Vector FI-2000 IF, IHC-F 1:100 
AMCA-conjugated anti-
mouse horse Vector CI-2000 IF 1:75 
AMCA-conjugated anti-
rabbit donkey Vector CI-1000 IF 1:75 
Texas Red-conjugated 
anti-mouse horse Vector TI-2000 IF, IHC-F 1:100 
Texas Red-conjugated 
anti-rabbit donkey Vector TI-1000 IF, IHC-F 1:100 
HRP-conjugated anti-
mouse rabbit Sigma Aldrich A9044 WB 1:5000 in milk 
HRP-conjugated anti-
rabbit goat Sigma Aldrich A0545 WB 1:5000 in milk 
 
 
4.2.4 X-Ray Irradiation and Tissue Sectioning: 
Cells and animals were irradiated in the RS-2000 Biological Research Irradiator (Rad-Source) at 
room temperature, with mock/control irradiated samples brought into the room to simulate the 
reduction in ambient temperature and account for any stress imparted by the travel.  Cells were 
always placed within the central circle directly under the x-ray source to maintain consistency in 
dose between samples.  Animals were anesthetized with isofluorane and placed on their back in 
the machine for whole-body irradiation to properly expose all tissues of interest to the x-ray 
source.  Accuracy of all doses was confirmed by dosimeter probe.  Both cells and animals were 
randomly assigned to individual timepoints or sham-irradiation controls.  
 
Following irradiation, mice were sacrificed at specific timepoints by CO2 asphyxiation and cervical 
dislocation.  Organs were harvested, placed in OCT media and frozen in liquid nitrogen.  Frozen 
tissues were sectioned on a cryostat machine at a thickness of 10μm, placed onto adhesive 
slides and stored at -80oC.  
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4.2.5 Western Blotting: 
Cellular protein lysates were collected in RIPA buffer, electrophoresed on 4-15% Tris-Glycine 
polyacrylamide gels (BioRad), transferred onto PVDF membranes and incubated overnight at 4oC 
with various primary antibodies followed by washing and secondary antibody incubation for 2hr at 
room temperature. Super ECL (GE/Pierce) was used as substrate for detection on 
autoradiography film or ChemiDoc MP digital system (BioRad).  
 
4.2.6 Immunofluorescence: 
Freshly frozen tissues were isolated from testis, brain, intestine and skin following 6Gy irradiation 
or 0Gy mock before embedding in OCT media and sectioning onto slides.  Slides of tissue 
sections or coverslips of cells were fixed in 4% formaldehyde and permeabolized with 0.2% 
Triton-X followed by blocking with 2% BSA. Tissues were incubated with primary antibodies in 1% 
BSA at 37oC for 3hr, washed and then incubated with secondary fluorescently-tagged secondary 
antibodies for 45min at 37oC.  Tissues were then mounted in place with coverslips containing 
mounting media with DAPI (Vector) for identification of nuclei.   
  
Cells were similarly fixed in 4% formaldehyde and permeabilized with 0.2% Triton-X before 
blocking.  For double-color staining, primary antibodies were incubated together for 1hr at 37oC 
followed by wash and incubation with fluorescently-tagged secondary antibodies for 30min at 
37oC.  For triple-color staining, following the original staining procedure, cells were incubated with 
1:1000 α-γH2AX antibody for 15min at 37oC followed by 12min incubation at 37oC with the 
appropriate secondary antibody.  Anti γH2AX antibody was chosen to match Sox2 to avoid cross-
reaction with the other target antigen of interest.  
 
 4.2.7 p300 siRNA Transfection and Molecular Inhibition 
For each sample. 563nM mouse EP300  or non-targeting control siGENOME SMARTpool siRNA 
(Dharmacon) was incubated together with 3.75% RNAiMAX lipofectamine transfection reagent 
(Invitrogen) in Opti-MEM media (Invitrogen) for 5min. siRNA complex was added to cells and 
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incubated in media without any antibiotic for 16h prior to irradiation, at a final concentration of 
51.2nM siRNA. For pharmacological inhibition of H3K56ac, bromodomain inhibitor I-CBP112 
(Cayman Chemical) was incubated with cells at a final concentration of 5µM prior to irradiation 
and washed from cells 30min later (unless cells were harvested earlier). 
 
4.2.8 Neutral Comet Assay: 
To assess repair of DNA double strand breaks, neutral comet assays were performed using 
CometSlide assay kits (Trevigen). Cells were collected at multiple timepoints following 6 Gy 
irradiation or 0 Gy mock and embedded in agarose on slides at equal concentrations. Slides were 
electrophoresed in TAE buffer, fluorescently stained with SYBR Green (Trevigen), and visualized 
by fluorescent microscopy. Olive comet moment was calculated using the CometScore software 
(TriTek) to analyze 50-100 comets per sample, with each series of timepoints repeated at least 
three independent times as both biological and technical replicates.  Individual comets were 
randomly selected for scoring from similar regions of the slide in all samples. Outliers were 
eliminated that fell greater than 1.5 standard deviations from the mean. Standard error was 
calculated for each cell type and timepoint normalized to the value of the 0min samples, while the 
significance of the difference between cell types over time was analyzed by Analysis of 
Covariance (ANCOVA) using XLStat statistical software (Addinsoft), with two-sided significance 
set at p<0.05.  Data from all samples was approximately normally distributed, and the standard 
deviation between samples within the same experiment was similar.  Samples were excluded 
from analysis only due to technical errors from the assay or cells being visibly unhealthy.   
 
4.2.9 Laser Microirradiation 
Stem cells (ES, NS) were co-plated with non-stem cells (ED, MEF) on glass coverslips and 
incubated for 2 days with 30μM BrdU (Sigma Aldrich) to sensitize DNA for DSB induction.  Prior 
to laser microirradiation, cells were incubated with Stem Cell cDy1 Dye (Active Motif) for 30min to 
fluorescently label live stem cells for identification.  Coverslips were then placed in circular 
magnetic chambers (Quorum Technologies) with media to be properly aligned for 
 103 
 
microirradiation.  Cells were microirradiated in a defined narrow region across adjacent stem and 
non-stem cells with 8000-12000 iterations of 405+633nm laser on the LSM 510 Confocal 
Microscope (Zeiss) at 45% power output. Care was taken to include stem (cDy1 positive) as well 
as non-stem cells in the DNA damage tracks. Cells were microirradiated for 20-30min per sample 
unless otherwise stated, with 6-12 regions of microirradiation per sample.   
 
3.2.10 Microscopy and Image Processing 
Micrographs were captured utilizing MetaSystems ISIS imaging software on Zeiss Axioplan2 
microscope or ZEN software on Zeiss LSM510 confocal microscope with the 20x, 63x or 100x 
objective lenses. Minimal threshold and contrast manipulation was performed equally across 
entire images. Controls were processed equally with treated samples. Adobe Photoshop CS3 
software was utilized for composing the collages of multiple pictures and labeling micrographs 
and Immunoblots in individual layers.  
 
3.2.11 Statistical Analysis 
A ‘two-tailed’ Student's t-test was used to calculate the statistical significance of the observed 
differences. In all cases, differences were considered statistically significant when  p<0.05. 
Unless otherwise indicated, values represent mean ± SEM. 
 
4.3 INTRODUCTION 
Chromosomal DNA is tightly wrapped around histone proteins to package and organize DNA into 
chromatin. Because DNA is so tightly bound by histones, their presence controls DNA access for 
biological processes such as DNA replication, gene transcription and DNA repair1. Histone modifications 
are often generalized into broad roles, promoting either the loosening or tightening of chromatin in order 
to encourage or repress nucleoprotein binding. Acetylation of lysine residues generally loosens chromatin 
by neutralizing the ionic charge between DNA and histones, while lysine methylations can be either 
activating or repressive depending on the specific residue. In addition to their broad cumulative effects on 
chromatin density, individual histone modifications have their own specific functions. Specific histone 
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modifications can serve as binding sites for recruiting proteins to DNA and controlling chromatin 
organization, depending on the geographical context of the residue. This series of specific functional 
modifications is known as the “histone code” 2. 
 
In addition to controlling DNA replication and gene transcription, many of these histone modifications are 
extremely important for a functioning DNA Damage Response (DDR) and effective DNA repair3,4. Histone 
modifications are involved in every step of the DDR, from chromatin opening to signaling and restoration 
of the basal state. While numerous histone modifications have been implicated in a broad range of DDR 
processes5, much is still unknown about the complexity of chromatin dynamics in response to DNA 
damage and during DNA repair. Additionally, all that is known about the epigenetics of the DDR comes 
from studies on cancer cells or transformed differentiated cells. To our knowledge there have not been 
any studies performed investigating the influence of particular histone modifications on the cellular 
response to DNA damage in stem cells. Stem cell pluripotency is regulated by unique chromatin 
organization along with distinctive expression of various histone modifications6–9. It is very likely that these 
same epigenetic marks which dictate gene expression also influence DNA access for repair factors and 
DDR signaling components. 
 
We established in previous chapters that normal stem cells exhibit a severely attenuated DDR resulting in 
insufficient DNA repair and promoting ionizing radiation (IR)-induced apoptosis. Here we examine the 
association between these radiation responses and unique epigenetic regulation. H2AX Y142 
phosphorylation status has been shown to influence cellular DNA damage sensitivity and the DDR10–12, 
and we demonstrate that failure to dephosphorylate H2AX Y142 around break sites in stem cells is 
strongly related to their radiosensitive phenotype. Moreover, the diminished DDR in stem cells is also 
associated with enhanced constitutive acetylation of histone 3 lysine 56 (H3K56ac), an epigenetic mark 
that may hinder the binding and retention of repair factors around double-strand breaks (DSBs)13,14. 
Reduction of H3K56ac through knockdown and inhibition of the acetyltransferase p300 protected stem 
cells from IR-induced apoptosis and restored DDR signaling. Our findings therefore indicate that stem 
cells exhibit an attenuated DDR through a unique regulation of chromatin structure. We deduce that 
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pluralistic epigenetic mechanisms act in concert to impede the DDR in normal stem cells, thus promoting 
their radiosensitivity. 
 
4.4 RESULTS 
 
4.4.1 DDR attenuation in stem cells is associated with a failure to dephosphorylate H2AX 
Y142 following DNA damage 
Tyrosine 142 (Y142) of histone H2AX is constitutively maintained in a phosphorylated state in 
chromatin, but dephosphorylation of H2AX-pY142 upon DNA damage has been determined to be 
required for recruitment of mediator of DNA damage checkpoint protein 1 (MDC1) to  nearby 
H2AX-pS139 (γH2AX) and subsequent downstream DDR signaling10,15. In the absence of Y142 
dephosphorylation, DDR signaling is blocked while apoptotic signaling is activated through 
binding of JNK14. We therefore investigated if the selective activation of apoptosis coincident with 
an attenuated DDR in stem cells could be explained by unique regulation of H2AX Y142 
phosphorylation. The presence of H2AX-pY142 was found mutually exclusive from γH2AX-
labeled microirradiation tracks of DNA damage in differentiated non-stem cells, while Y142 
remained prominently phosphorylated in stem cells where γH2AX was abrogated (Fig. 4.1 A-B). 
Immunoblotting also confirmed that Y142 is dephosphorylated at the break sites only in non-stem 
cells following IR (Fig. 4.2) MDC1 was also found not to be recruited to the tracks of DNA 
damage in stem cells (Fig. 4.3A) and H2AX-pY142 was absent from MDC1-labeled tracks only in 
non-stem cells (Fig. 4.3B). These data surmise that stem cells are primed to apoptose in lieu of 
DNA repair signaling by the maintenance of constitutive H2AX Y142 phosphorylation following 
DNA damage. 
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Figure 4.1. H2AX-pY142 persists along DSBs only in cultured stem cells. Immunofluorescence co-
staining of Sox2 (blue) H2AX-pY142 (green), and γH2AX (red) on co-plated ES and ED cells following 
microirradiation. (A)White arrowheads indicate H2AX-pY142 dephosphorylation at γH2AX-labeled DNA 
breaks only in non-stem cells. (B)Arrowhead marks the path of microirradiation across the stem cell. 
Individual ES and ED pictures shown were irradiated together following co-plating. White scale bars, 10μm. 
Figure 4.2. Global H2AX-pY142 is reduced following irradiation only in non-stem cells. Western 
blots for phosphorylated H2AX-pY142 at 15min following mock or 6Gy irradiation of ES and ED cells. 
GAPDH served as a loading control. 
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4.4.2 The absence of IRIFs inversely correlates with high H3K56ac levels in stem cells 
Chromatin structure has been shown to have a major influence on DNA repair3. Our screening for 
histone modifications implicated in DDR using blastocyst stage embryos and isogenic stem/ non-
stem cells, identified histone H3 lysine 56 acetylation as a potential epigenetic regulator of stem 
cell radiation response. H3K56ac has been implicated as a DNA damage-responsive histone 
modification13,14,16–18, is known to be directly involved in maintaining the pluripotent state of 
embryonic stem cells7,19, and is elevated in undifferentiated cells17. We therefore investigated 
whether enhanced H3K56ac levels in stem cells may be related to the observed attenuation DDR 
signaling. We elucidated that H3K56ac levels were dramatically enhanced within the inner cell 
Figure 4.3 MDC1 is not recruited to DSBs in cultured stem cells. Immunofluorescence co-staining of 
(A) Sox2 (green) and MDC1 (red) or (B) Sox2 (green), MDC1 (red), and H2AX-pY142 (blue) on co-plated 
ES and ED cells following microirradiation. Individual ES and ED pictures shown were irradiated together 
following co-plating. White scale bars, 10μm. 
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mass of embryos where stem cells are located (Fig. 4.4 A), and high H3K56ac levels in cultured 
ES cells sharply decreased upon differentiation (Fig. 4.4 B). Interestingly, high H3K56ac levels 
were associated with an absence of γH2AX foci following irradiation of culture cells (Fig. 4.5). 
This phenomenon was also observed in vivo, where high H3K56ac levels in stem cells 
corresponded to strongly abrogated DDR signals (Fig. 4.6).  
 
 
 
 
Figure 4.4. H3K56ac is enhanced in ES cells compared to differentiated progeny.      
(A) Immunofluorescence staining for H3K56ac (red) or total histone H3 (green) on 
unirradiated E4.5 day mouse embryos. (B) Immunofluorescence co-staining of Sox2 (green) 
and H3K56ac (red) on an unirradiated, partially differentiated ES cell colony. DAPI=DNA. 
White scale bars, 10μm. 
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Figure 4.5. Elevated H3K56ac levels in culture cells correlates with attenuated γH2AX 
induction. Immunofluorescence co-staining of γH2AX (green) and H3K56ac (red) on co-plated 
ES and ED cells 15min following 2Gy IR. DAPI=DNA. White scale bars, 10μm. 
Figure 4.6. Elevated H3K56ac levels in stem cell regions correlates with attenuated γH2AX 
induction. Immunofluorescence co-staining of H3K56ac (red) and γH2AX (green) in tissue niches 15min 
following 6Gy IR. DAPI=DNA.  Arrowheads indicate cells expressing high H3K56ac and an absence of 
γH2AX foci. White scale bars, 10μm. 
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4.4.3 Stem cells lack transient reduction of H3K56ac in chromatin around DSB sites    
We utilized microirradiation tracks to investigate any differential kinetics of H3K56ac changes 
around DNA break sites in stem and non-stem cells at different timepoints after induction of DNA 
damage. Our results revealed that acetylation of H3K56ac was significantly reduced along the 
γH2AX tracks within minutes of DNA damage only in non-stem cells, while in stem cells 
attenuated γH2AX corresponded with constitutively elevated H3K56ac levels that did not 
substantially change in the region of DNA damage (Fig. 4.7 A-B). H3K56ac reduction was due to 
decreased acetylation and not eviction of histones from the break site, as histone H3 levels did 
not change along the track of DNA damage (Fig. 4.8). This reduction in H3K56ac at break sites in 
non-stem cells that display robust DDR signaling was found to be transient in nature. No 
alteration was observed in either stem or non-stem cells at 30min or 1h following microirradiation 
(Fig. 4.9 A-B), indicating that alteration of chromatin structure may only be necessary for initial 
induction and maintenance of the DDR immediately following DNA damage.  Constitutively 
enhanced H3K56ac in stem cells without any reduction at break sites is therefore associated with 
hampered recruitment/ retention of DDR factors to DNA breaks. 
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Figure 4.7. H3K56ac is reduced in non-stem but not stem cells along DSBs.                                 
(A) Immunofluorescence co-staining of Sox2 (green), γH2AX (red) and H3K56ac (blue) on co-plated ES 
and ED cells 10min following microirradiation. Arrowhead marks the path of laser microirradiation across 
the stem cell. (B) Signal intensity profiles of microirradiated ES and ED cells demonstrate the 
relationship between H3K56ac (blue) and yH2AX (red) across the break site. Red lines across the nuclei 
indicate the path of signal intensity measurements. Sox2=green. Individual ES and ED pictures shown 
were irradiated together following co-plating. White scale bars, 10μm. 
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Figure 4.8. Histones are not evicted from chromatin along DSBs in stem or non-stem cells. 
Immunofluorescence co-staining of Sox2 (green), γH2AX (red) and histone H3 (blue) on co-plated ES 
and ED cells 10min following microirradiation. Individual ES and ED pictures shown were irradiated 
together following co-plating. White scale bars, 10μm. 
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4.4.4 Knockdown and inhibition of p300 acetyltransferase reduces H3K56ac levels 
Having established a negative correlation between H3K56ac expression and γH2AX induction, 
we wanted to determine whether we could modulate H3K56ac levels in order to more directly 
assess its effect on radiosensitivity and the DDR in stem cells. The H3K56ac acetyltransferase 
p300 was extremely elevated in both unirradiated and irradiated stem cells in culture (Fig. 4.10-
11), only displaying minimal observable expression in differentiated cells. p300 expression also 
parallelled elevated H3K56ac levels in mixed culture (Fig. 4.12). siRNA knockdown substantially 
reduced H3K56ac levels (Fig. 4.13), although the reduction was transient likely due to 
compensatory effects from other acetyltransferases. We therefore confirm that p300 is an 
acetyltransferase for H3K56ac, and its knockdown provides a suitable method for H3K56ac 
downregulation. 
Figure 4.9. Baseline H3K56ac levels are restored along DSBs in non-stem cells within 30min of 
microirradiation. Immunofluorescence co-staining of Sox2 (green), γH2AX (red) and H3K56ac (blue) 
on co-plated ES and ED cells (A) 30min or (B) 1h following microirradiation. Individual ES and ED 
pictures shown were irradiated together following co-plating. White scale bars, 10μm. 
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Figure 4.10 Expression of p300 acetyltransferase is substantially higher in stem cells as 
compared to non-stem cells. Western blots for p300 at multiple timepoints following mock or 6Gy 
irradiation of ES and ED cells. GAPDH served as a loading control. 
 
Figure 4.11. Elevated p300 expression corresponds with Sox2 expression in ES colonies. 
Immunofluorescence co-staining of p300 (green) and Sox2 (red) on an unirradiated, partially 
differentiated ES cell colony. DAPI=DNA. White scale bars, 10μm. 
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Figure 4.12. Elevated p300 expression corresponds with elevated H3K56ac in ES colonies. 
Immunofluorescence co-staining of p300 (green) and H3K56ac (red) on an unirradiated, partially 
differentiated ES cell colony. DAPI=DNA. White scale bars, 10μm. 
Figure 4.13. siRNA knockdown of p300 transiently downregulates H3K56ac in cultured stem 
cells. Western blots for p300 and H3K56ac at multiple timepoints in ES cells following 16h 
incubation with negative control or p300 siRNA. GAPDH served as a loading control. 
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4.4.6 Reducing H3K56ac levels imparts radioprotection on stem cells through restoration 
of the DDR 
Being able to downregulate H3K56ac allowed us to determine whether enhanced H3K56ac levels 
are truly responsible for the abrogation of the DDR in stem cells. p300 knockdown (and 
associated H3K56ac reduction) in stem cells increased global induction of γH2AX (Fig 4.14) 
following irradiation. We then performed a comet assay to assess whether an enhanced DDR due 
to decreased H3K56ac levels could successfully improve DNA repair proficiency. Knockdown of 
p300 in stem cells resulted in significant improvement in DNA repair efficacy as indicated by a 
hastened reduction in DNA breaks (Fig. 4.15). We then examined whether this improved DNA 
repair through increased DDR signaling was sufficient to reduce stem cell radiosensitivity. IR-
induced apoptosis was significantly reduced in stem cells following p300 knockdown (Fig. 4.16), 
determining that constitutively elevated H3K56ac in stem cells is indeed a major contributor to 
their IR hypersensitivity. p300 knockdown had no effect on either baseline or IR-induced cell 
death in non-stem cells, indicating that H3K56ac modulation can be utilized to specifically 
regulate radiosensitivity in stem cells without unintended effects on other cell types. 
 
 
Figure 4.14. p300 knockdown increases γH2AX induction in cultured stem cells following 
irradiation. Western blot for γH2AX at 15min following either sham or 6Gy IR of ES cells after 16h 
incubation with negative control or p300 siRNA. GAPDH served as a loading control. 
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Figure 4.15. p300 knockdown improves DNA repair in cultured stem cells. Olive moments of NS 
and ND cell comet assay tails were quantified at different timepoints following sham or 6Gy IR after 16h 
incubation with negative control or p300 siRNA. Olive moments were normalized to the irradiated 0min 
timepoint in order to measure DNA repair over time. N=3. Error bars indicate SEM. 
 
Figure 4.16. p300 knockdown reduces IR-induced apoptosis in stem cells without any effect 
on non-stem cells. Flow cytometric analysis of apoptosis comparing ES and ED cells by Annexin-V 
labeling 16h following sham or 6Gy IR after 16h incubation with negative control or p300 siRNA. N=3; 
** = p < 0.01; Error bars indicate SEM. 
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4.5 DISCUSSION 
Our work from previous chapters showed that despite being able to sense DSBs through the Mre11-
Nbs1-Rad50 (MRN) complex, downstream DDR signaling is abrogated in stem cells. Since stem cells are 
able to sense broken DNA, they must have some inhibitory mechanism(s) blocking DDR factors from 
accessing/ accumulating around DSBs. Our data suggests that the failure of stem cells to 
dephosphorylate H2AX-pY142 following DNA damage blocks DDR signaling and instead induces 
apoptosis through c-Jun N-terminal kinase (JNK). This epigenetic mechanism explains how stem cells 
can undergo IR-induced apoptosis without active DDR signaling (Supplementary Fig. 4b). In addition to 
providing novel evidence that unique regulation of H2AX Y142 phosphorylation status in stem cells may 
regulate their radiosensitivity, this study also suggests that H2AX-pY142 may directly inhibit S139 γH2AX 
phosphorylation. While it is unclear whether H2AX-pY142 is directly blocking the initial phosphorylation of 
H2AX-S139 in stem cells or if Y142 phosphorylation merely prevents MDC1-mediated amplification of 
γH2AX20 along the break site; regulation of H2AX-pY142 appears to influence cellular responses to DNA 
damage. We propose that the close proximity of H2AX-pY142 sterically hinders access to the H2AX-S139 
site, therefore blocking γH2AX phosphorylation and/or MDC1 binding.  
 
H2AX-pY142 is also related to the apoptotic induction of mammalian sterile 20–like kinase-1 (MST1) and 
pan-nuclear H2AX-pS139. MST1 is required for imatinib-mediated apoptosis through H2AX-pY142 21 
(likely involving pJNK). Additionally, apoptotic H2AX-pS139 has been directly linked to both MDC1 
inhibition 22 and enhanced Y142 phosphorylation 21. Our work suggests that H2AX-pY142 may directly 
inhibit γH2AX at S139, although it is unclear whether H2AX-pY142 is directly blocking the initial 
phosphorylation of H2AX-S139 in stem cells or merely preventing MDC1-mediated amplification of γH2AX 
along the break site. We propose that the close proximity of H2AX-pY142 sterically hinders access to the 
S139 site, therefore blocking γH2AX induction and/or MDC1 binding. This mechanism explains how DDR 
signaling is inhibited in stem cells despite proper sensing of DSBs. 
 
We also elucidated that continuously elevated H3K56ac in stem cells is associated with abrogated 
induction of the DDR following DNA damage. Existing literature has primarily only assessed global 
 119 
 
changes in H3K56ac, with contradictory results concerning whether levels increase 16,17 or decrease 
13,14,23 following genotoxic stress. In one of the few studies that assessed local H3K56ac changes around 
break sites, however, Miller et al. demonstrated that H3K56ac is absent from γH2AX within 
microirradiated regions of DNA damage in cancer cells14, providing  rationale to investigate whether 
enhanced levels of H3K56ac in stem cells are mechanistically associated with an abrogated DDR. These 
inconsistencies may result from the dynamic nature of the H3K56ac radioresponse14,24, and our results 
confirm that DNA damage-induced depletion of H3K56ac occurs only transiently during the early stages 
of DDR signaling. H3K56ac is required for chromatin reassembly at the end of DSB repair in yeast25, 
however this may merely explain why H3K56ac levels are so quickly restored to baseline following 
transient reduction. Histone deacetylation at specific sites may also be the mechanism responsible for the 
transient compaction of chromatin locally surrounding DSBs that has been found to be important for 
proper DDR signaling26. The temporal response of H3K56ac to DNA damage suggests dynamic interplay 
of associated histone deacetylases and acetyltransferases around DNA break sites. While histone 
acetylation is generally associated with the overall loosening of chromatin, acetylation at specific residues 
such as H3K56 may create a non-permissive chromatin environment for DNA repair, either blocking 
access for recruitment of repair factors or allowing binding of repressor proteins that could restrict IRIF 
maturation.  
 
While several acetyltransferases13,16,17 and deacetylases14,17,18,27 have been shown to effect mammalian 
H3K56ac levels13,16,17, we chose to target p300 acetyltransferase for modulation of H3K56ac levels. p300 
has been implicated in H3K56ac regulation by many studies and mirrors H3K56ac recruitment to ES-
specific genes7,19,28. In addition to its role as an acetyltransferase, p300 and the related CREB-binding 
protein (CBP) also act as transcriptional coactivators by directing assembly of transcriptional machinery at 
promoter regions29,30. p300 and CBP also play a role in the induction of apoptosis, primarily through their 
regulation of p53.  p300 binding to p53 may promote its degradation under basal conditions, but upon 
cellular stress p300/CBP acetylation of p53 promotes p53 transcriptional activation of target genes29,31–34.  
Additionally, p300 and CBP are also mutated in many cancers35 and p300 (but not CBP) loss has been 
shown to impair apoptosis in culture cells36.  It is therefore plausible that p300 knockdown could reduce 
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radiosensitivity independent of H3K56ac.  Several lines of evidence suggest that reduced p53 activation 
is not responsible for improved radioresponses in stem cells following p300 knockdown, however. Neither 
p53 37 or its upstream kinase ataxia telangiectasia mutated (ATM) (Fig. 3.19) is required for DNA 
damage-induced apoptosis in stem cells. Additionally, p300 knockdown only affected radiosensitivity in 
stem cells where enhanced H3K56ac levels are the most predominant p300-related phenotype. These 
data suggests that there may be a threshold level of H3K56ac expression during DDR signaling above 
which the recruitment of repair factors is inhibited. H3K56ac reduction therefore has no effect in 
differentiated cells with basally low levels of H3K56ac and the ability to downregulate H3K56ac along 
DSBs, however it has a substantial effect on the radiation responses of stem cells.  Based on the large 
difference in p300 expression between stem and non-stem cells, it is also possible that H3K56ac 
regulation in stem cells is more p300-dependent than other cell types, and therefore p300 knockdown 
only has a significant effect on stem cells. Either way, these possibilities postulate that H3K56ac 
modulation may be used to specifically radioprotect stem cells without any effect on differentiated or 
cancer stem cells. 
 
Successful restoration of DDR signaling and the associated reduction in IR-induced apoptosis in stem 
cells following H3K56ac downregulation indicates that elevated H3K56ac directly contributes to stem cell 
radiosensitivity by preventing proper recruitment and retention of DDR factors.  Because H3K56ac 
modulation only affected the radiosensitivity of stem cells, p300 and other H3K6ac regulators may serve 
as useful pharmacological targets for preventing stem cell dropout during radiation therapy.  Protecting 
stem cells will minimize clinical consequences of radiation therapy and allow the use of higher doses for 
more effective cancer treatment. 
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5.1 SUMMARY 
Radiation therapy utilizes targeted ionizing radiation (IR) to induce double-strand breaks (DSBs) in cancer 
cells, leading to destruction of the tumor. While every effort is made to spare normal tissue, nevertheless 
patients often experience detrimental clinical consequences following radiation therapy as a result of 
damaged normal tissue. There are several mechanisms of long-term radiation injury; this project focused 
on the loss of regenerative capacity in proliferative tissues resulting in functional sequelae following 
normal tissue turnover. Due to the loss of regenerative capacity and observable damage to the stem cell 
compartment, this form of radiation injury has been attributed to stem cell dropout. Despite this 
association, conflicting evidence exists concerning the true radiosensitivity of stem cells themselves 
compared to surrounding differentiated cells within their respective tissue niche. Previous studies have 
only investigated specific stem cell compartments or individual cell culture models. Stem cell culture 
models typically involve high-passage, established cell lines and do not compare stem cells with their 
directly differentiated isogenic progeny. In order to identify conserved molecular mechanisms underlying 
stem cell radiation responses, we investigated stem cell radiosensitivity in four clinically relevant stem cell 
niches as well as two primary, early passage culture models from mice. In vivo stem cell compartments 
assayed in this project included the subventricular zone within the dentate gyrus of brain, the 
seminiferous tubules of testis, the hair follicle in skin and intestinal crypts. For culture models, embryonic 
stem (ES) cells were isolated from the inner cell mass of blastocyst-stage embryos and neural stem (NS) 
cells were freshly dissected from the hippocampus of P0-P2 mouse pups.  Both culture models were 
directly differentiated by removal of growth factors from media and assayed in parallel with their 
differentiated progeny. 
 
Whole-body irradiation of mice induced apoptosis exclusively within individually labeled stem cells of all 
four tissue niches and this differential radiosensitivity was recapitulated in both culture models. Dose 
curves determined that stem cells are radiosensitive at as low as 2Gy while differentiated cells only begin 
to apoptose above 8Gy. While the long-held tenet of radiobiology known as the Law of Bergonié and 
Tribondeau states that radiosensitivity is directly related to proliferation rate, we found no association 
between proliferation status and radiosensitivity among our stem cell models. While radiosensitivity 
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differences among differentiated cell populations correlated with proliferation status, enhanced 
radiosensitivity in stem cells was not associated with enhanced proliferation.  Radiation responses did 
differ between stem and non-stem cells across the cell cycle however, as stem cells apoptosed much 
more broadly across the cell cycle. Stem cells are therefore hypersensitive to IR independent of their 
proliferation status, in contrast with their radioresistant differentiated progeny. 
 
Investigation of DDR signaling among stem and differentiated cells elucidated that stem cells both in vivo 
and in culture exhibit a strongly attenuated DDR as indicated by substantially reduced induction of γH2AX 
as well as reduced activation and recruitment of phosphorylated ATM. Muted DDR signaling in stem cells 
was associated with inadequate DNA repair and improper cell cycle checkpoint arrest. Despite the 
absence of γH2AX foci, at late timepoints stem cells exhibited apoptotic pan-nuclear H2AX 
phosphorylation at the same S139 as part of the MST1-JNK-H2AX pathway. Diminished DDR signaling in 
stem cells is therefore associated with their radiosensitivity.  
 
Stem cells also showed a unique persistence of H2AX Y142 around break sites, resulting in hindered 
recruitment of the DDR factor MDC1 and instead prompting JNK-mediated apoptosis. Failure to 
dephosphorylate H2AX Y142 may thus direct stem cells toward apoptosis in lieu of DNA repair.  Histone 
3 lysine 56 acetylation (H3K56ac) was found to be elevated in stem cells and was inversely correlated 
with robust induction of γH2AX foci both in vivo and in culture. H3K56ac was reduced along break sites in 
differentiated but not stem cells, and H3K56ac downregulation reduced IR-induced apoptosis in stem 
cells through restoration of the DDR. Unique epigenetic regulation can thereby promote heterogeneous 
radiation responses among different cell types. Therapeutic modulation of these histone modifications 
may protect stem cells from IR and thus allow more efficient treatment of cancer patients. 
 
5.2 ONGOING WORK AND FUTURE DIRECTIONS 
5.2.1 H3K56ac 
We are continuing to investigate the contribution of H3K56ac toward stem cell radiosensitivity. 
Preliminary evidence suggests that the presence of elevated H3K56ac and its persistence along 
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DSBs is hindering DDR signaling. It is unclear at which step H3K56ac might be interrupting DDR 
progression. H3K56ac may prevent initial ATM kinase recruitment to DSBs, blocking its activation 
and phosphorylation of H2AX at S139. H3K56ac may also be acting through its effect on H2AX-
pY142, blocking recruitment of EYA phosphatase which is responsible for H2AX Y142 
phosphorylation1. H3K56ac could even itself be inhibiting expansion of γH2AX around the DSB 
and thereby blocking DDR amplification. A whole series of experiments will be required to parse 
apart the specific locations in the pathway at which H3K56ac is acting. 
 
  5.2.1.1 Targeting ASF1 and the p300/CBP bromodomain  
Current experiments are focusing on alternative methods for reducing H3K56ac levels 
aside from p300 knockdown. In addition to its acetyltransferase activity, p300 also 
functions as a transcriptional co-activator2, so it would be useful to parse apart these 
functions. The bromodomain of p300 and its sister protein CBP binds acetylated lysines 
on target proteins3,4 and is necessary for efficient acetylation of these proteins as well.  
While p300/CBP can promote aggregation of transcription factors at promoter regions 
through a distinct activation domain2, its transcriptional coactivation function is often 
acetylation-dependent for proteins such as p53 3. Acetylation of H3K56 may possibly be 
more precisely targeted by modulation of the interaction with ASF1, a histone chaperone 
that promotes p300/CBP mediated acetylation of H3K56 5–8. ASF1 mutually interacts with 
the bromodomain and H3K56ac to conformationally promote histone acetylation. While 
the bromodomain can bind various acetylated lysines, CBP bromodomain binding has 
been found to most strongly interact with H3K56ac. Additionally, ASF1 specifically 
promotes acetylation of H3K56ac. We have therefore begun experiments utilizing I-
CBP112, a p300/CBP-specific bromodomain inhibitor that has been shown to selectively 
reduce H3K56ac, potentially acting through disruption of the ASF1-bromodomain-H3K56 
interaction. In addition to potentially improving specificity towards H3K56ac, 
pharmacological inhibition will also allow more precise temporal control of H3K56ac 
modulation. Genetic knockdowns of ASF1 may also produce H3K56ac-specific 
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downregulation, although this may prove less effective for improving repair as ASF1-
mediated H3K56ac is required for DDR recovery through γH2AX dephosphorylation and 
basal chromatin reassembly6,9.  
 
5.2.1.2 H3K56ac upregulation and targeted chromatin modulation 
In parallel with downregulation of H3K56ac in stem cells, we would like to investigate 
whether upregulation of H3K56ac can impart enhanced radiosensitivity to differentiated 
cells.  This could be performed through overexpression of p300 by plasmid transfection, 
pharmacological molecular activators, or newly-developed CRISPR-based transcriptional 
activation (Santa Cruz). Similarly, knockout and inhibition of various histone deacetylases 
could be used, although multiple deacetylases have been shown to act on 
H3K56ac7,8,10,11 and they are unlikely to exhibit much specificity. Reversing the 
radiosensitivity phenotype in both directions would thoroughly confirm the hypothesis and 
provide insights into both radioprotection and radiosensitization. H3K56ac and its 
relationship to the DDR is likely complicated however, and simple upregulation may not 
be sufficient to modify radiation responses. Additionally, the dynamic influence of the 
various acetyltransferases and deacetylases on H3K56ac may differ among stem and 
differentiated cells. Nonetheless, attempting H3K56ac upregulation in differentiated cells 
will be a worthwhile experiment. 
 
A major issue with existing epigenetics research is the difficulty of modulating chromatin 
at designated sites. Knockdown or inhibition of an acetyltransferase or deacetylase will 
affect global acetylation levels, producing pleiotropic effects that may be hard to directly 
attribute to changes specifically at the break site. New technologies however enable 
tethering and recruitment of chromatin modifying enzymes to DNA DSBs. The Misteli Lab 
has developed an effective system utilizing I-Sce1 endonuclease recognition sites 
bordered by LacO/TetO sequences. Integrated I-Sce-I will only cut at the inserted 
recognition site to produce a site-specific DSB, and chromatin modifiers can be tethered 
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to additionally transfected LacR/TetR repressor which will recruit them to the DSB at the 
LacO/TetO sites12,13. A similar procedure can be performed using CRISPR technology 
with catalytically-inactive Cas9 endonuclease14. These methods could allow more precise 
analysis of H3K56ac effects specific to the region around DSBs. 
 
5.2.2 Cancer Stem Cells 
Cancer stem cells (CSCs) are a unique cell type that while still debated are generally believed to 
exist at the core of many tumors. Similar to normal stem cells, cancer stem cells are capable of 
regenerating all other cells of a tumor and therefore must be destroyed in order to prevent 
recurrence15. It is unclear whether cancer stem cells originate from the de-differentiation of 
radioresistant differentiated cells or the transformation of normal stem cells, but either way the 
majority of evidence suggests that they are extremely radioresistant15–17 yet exhibit an 
undifferentiated stem cell-like phenotype. Several factors contribute to impart complex and often 
unique concerted mechanisms of radioresistance in CSCs15–20, and it would be extremely 
interesting to compare their radiation responses to those in normal stem and differentiated cells.  
While an elevated DDR has been implicated in cancer stem cell radioresistance17, a failure to 
induce γH2AX has been shown in breast CSCs21. Parallel comparison of the IR-responsive 
mechanisms and epigenetic regulation examined in this project among stem, differentiated, and 
cancer stem cells would provide additional context for the uniqueness of stem cell radiation 
responses and how to best target radioprotective therapies. 
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